<SEC-DOCUMENT>0000950103-25-014670.txt : 20251113
<SEC-HEADER>0000950103-25-014670.hdr.sgml : 20251113
<ACCEPTANCE-DATETIME>20251113143320
ACCESSION NUMBER:		0000950103-25-014670
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251113
DATE AS OF CHANGE:		20251113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251477431

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237315_424b2-8022ubs.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Pricing Supplement dated November 11, 2025</FONT></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Filed Pursuant to Rule 424(b)(2)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Registration Statement No. 333-287303</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt">$3,000,000
Barclays Bank PLC Trigger Autocallable Contingent Yield Notes with Memory Coupon Feature</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Linked to the lesser performing of the common stock of Microsoft
Corporation and the common stock of Oracle Corporation due December 16, 2026</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; font-size: 10pt; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Investment Description</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Trigger Autocallable Contingent Yield Notes (the &ldquo;Notes&rdquo;)
are unsecured and unsubordinated debt obligations issued by Barclays Bank PLC (the &ldquo;Issuer&rdquo;) linked to the lesser performing
of the common stock of Microsoft Corporation and the common stock of Oracle Corporation (each an &ldquo;Underlying&rdquo; and together
the &ldquo;Underlyings&rdquo;). On a monthly basis, unless the Notes have been previously called, the Issuer will pay you a coupon (the
&ldquo;Contingent Coupon&rdquo;), plus all previously unpaid Contingent Coupons, if any, if the Closing Price of each Underlying on the
applicable Observation Date is greater than or equal to its specified Coupon Barrier. Otherwise, no Contingent Coupon will be paid for
that month. The Issuer will automatically call the Notes if the Closing Price of each Underlying on any monthly Observation Date is greater
than or equal to its Closing Price on the Strike Date (the &ldquo;Initial Underlying Price&rdquo;). If the Notes are automatically called,
the Issuer will pay the principal amount of your Notes <I>plus</I> the Contingent Coupon and any previously unpaid Contingent Coupons
due on the Coupon Payment Date that is also the Call Settlement Date, and no further amounts will be owed to you under the Notes. If the
Notes are not automatically called and the Closing Price of each Underlying on the Final Valuation Date (the &ldquo;Final Underlying Price&rdquo;)
is greater than or equal to its specified Downside Threshold (which is set equal to its Coupon Barrier), the Issuer will pay you a cash
payment at maturity equal to the principal amount of your Notes <I>plus</I> the Contingent Coupon and any previously unpaid Contingent
Coupons due on the Coupon Payment Date that is also the Maturity Date. However, if the Notes are not automatically called and the Final
Underlying Price of either Underlying is less than its Downside Threshold, at maturity, the Issuer will deliver to you a number of shares
of the Underlying with the lower Underlying Return (the &ldquo;Lesser Performing Underlying&rdquo;) equal to the principal amount per
Note divided by the Initial Underlying Price of the Lesser Performing Underlying (the &ldquo;Share Delivery Amount&rdquo;) for each of
your Notes, which shares are expected to be worth significantly less than your principal amount and may have no value at all. If you receive
shares of the Lesser Performing Underlying at maturity, the Issuer will pay cash in lieu of delivering any fractional shares of the Lesser
Performing Underlying in an amount equal to that fraction times the Final Underlying Price of the Lesser Performing Underlying. <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Investing
in the Notes involves significant risks. You may lose a significant portion or all of your principal. You may receive few or no Contingent
Coupons during the term of the Notes. You will be exposed to the market risk of each Underlying and any decline in the price of one Underlying
may negatively affect your return and will not be offset or mitigated by a lesser decline or any potential increase in the price of the
other Underlying. The Final Underlying Price of each Underlying is observed relative to its Downside Threshold only on the Final Valuation
Date, and the contingent repayment of principal applies only if you hold the Notes to maturity. You may receive shares at maturity that
are expected to be worth significantly less than your principal amount and may have no value at all. Generally, the higher the Contingent
Coupon Rate on a Note, the greater the risk of loss on that Note. Your return potential on the Notes is expected to be limited to any
Contingent Coupons paid on the Notes, and you are not expected to participate in any appreciation of either Underlying. Any payment on
the Notes, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any
third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power
(as described on page PS-4 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts owed
to you under the Notes. See &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo; in the
accompanying prospectus supplement.</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 58%; background-color: #788D41; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Features</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; background-color: #788D41; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Key Dates<SUP>1</SUP></B></FONT></TD></TR>
  </TABLE>
<DIV STYLE="float: left; width: 58%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-indent: 0in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD STYLE="width: 95%; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Contingent Coupon:</B></FONT> <FONT STYLE="font-size: 10pt">Unless the Notes have been previously called, the Issuer will pay you a Contingent Coupon for each month, plus all previously unpaid Contingent Coupons, if any, if the Closing Price of each Underlying on the applicable Observation Date is greater than or equal to its Coupon Barrier. Otherwise, no Contingent Coupon will be paid for that month.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">q</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Automatic Call:</B></FONT> <FONT STYLE="font-size: 10pt">The Issuer will automatically call the Notes if the Closing Price of each Underlying on any monthly Observation Date is greater than or equal to its Initial Underlying Price. If the Notes are automatically called, the Issuer will pay the principal amount of your Notes <I>plus</I> the Contingent Coupon and any previously unpaid Contingent Coupons due on the Coupon Payment Date that is also the Call Settlement Date, and no further amounts will be owed to you under the Notes.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Wingdings">q</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Downside Exposure with Contingent Repayment of Principal at Maturity:</B></FONT> <FONT STYLE="font-size: 10pt">If the Notes are not automatically called and the Final Underlying Price of each Underlying is greater than or equal to its Downside Threshold, the Issuer will pay you a cash payment at maturity equal to the principal amount of your Notes <I>plus</I> the Contingent Coupon and any previously unpaid Contingent Coupons due on the Coupon Payment Date that is also the Maturity Date. However, if the Notes are not automatically called and the Final Underlying Price of either Underlying is less than its Downside Threshold, at maturity, the Issuer will deliver to you a number of shares of the Lesser Performing Underlying equal to its Share Delivery Amount for each of your Notes, which shares are expected to be worth significantly less than your principal amount and may have no value at all. If you receive shares of the Lesser Performing Underlying at maturity, the Issuer will pay cash in lieu of delivering any fractional shares of the Lesser Performing Underlying in an amount equal to that fraction times the Final Underlying Price of the Lesser Performing Underlying. The Final Underlying Price of each Underlying is observed relative to its Downside Threshold only on the Final Valuation Date, and the contingent repayment of principal applies only if you hold the Notes to maturity. Any payment on the Notes, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="float: right; width: 40%">

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Strike Date:</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">November 10, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Trade Date:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 11, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Settlement Date:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">November 14, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Observation Dates:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Monthly (see page PS-10)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Final Valuation Date:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">December 11, 2026</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Maturity Date:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">December 16, 2026</FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>With respect to each Underlying, the Initial Underlying Price is the Closing Price of that Underlying on the Strike Date and is not the Closing Price of that Underlying on the Trade Date. </I></B></FONT><FONT STYLE="font-size: 10pt">The Observation Dates, including the Final Valuation Date, and the Maturity Date are subject to postponement. See &ldquo;Final Terms&rdquo; on page PS-6 of this pricing supplement.</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>NOTICE TO INVESTORS: THE NOTES ARE SIGNIFICANTLY RISKIER THAN CONVENTIONAL DEBT INSTRUMENTS. THE ISSUER IS NOT NECESSARILY OBLIGATED TO REPAY THE FULL PRINCIPAL AMOUNT OF THE NOTES AT MATURITY, AND THE NOTES CAN HAVE THE FULL DOWNSIDE MARKET RISK OF THE LESSER PERFORMING UNDERLYING. THIS MARKET RISK IS IN ADDITION TO THE CREDIT RISK INHERENT IN PURCHASING A DEBT OBLIGATION OF BARCLAYS BANK PLC. YOU SHOULD NOT PURCHASE THE NOTES IF YOU DO NOT UNDERSTAND OR ARE NOT COMFORTABLE WITH THE SIGNIFICANT RISKS INVOLVED IN INVESTING IN THE NOTES.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>YOU SHOULD CAREFULLY CONSIDER THE RISKS DESCRIBED UNDER &ldquo;KEY
RISKS&rdquo; BEGINNING ON PAGE PS-11 OF THIS PRICING SUPPLEMENT AND &ldquo;RISK FACTORS&rdquo; BEGINNING ON PAGE S-9 OF THE PROSPECTUS
SUPPLEMENT BEFORE PURCHASING ANY NOTES. EVENTS RELATING TO ANY OF THOSE RISKS, OR OTHER RISKS AND UNCERTAINTIES, COULD ADVERSELY AFFECT
THE MARKET VALUE OF, AND THE RETURN ON, YOUR NOTES. YOU MAY LOSE A SIGNIFICANT PORTION OR ALL OF YOUR PRINCIPAL AMOUNT. THE NOTES WILL
NOT BE LISTED ON ANY SECURITIES EXCHANGE.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>NOTWITHSTANDING AND TO THE EXCLUSION OF ANY OTHER TERM OF THE NOTES
OR ANY OTHER AGREEMENTS, ARRANGEMENTS OR UNDERSTANDINGS BETWEEN BARCLAYS BANK PLC AND ANY HOLDER OR BENEFICIAL OWNER OF THE NOTES (OR
THE TRUSTEE ON BEHALF OF THE HOLDERS OF THE NOTES), BY ACQUIRING THE NOTES, EACH HOLDER OR BENEFICIAL OWNER OF THE NOTES ACKNOWLEDGES,
ACCEPTS, AGREES TO BE BOUND BY AND CONSENTS TO THE EXERCISE OF, ANY U.K. BAIL-IN POWER BY THE RELEVANT U.K. RESOLUTION AUTHORITY. SEE
&ldquo;CONSENT TO U.K. BAIL-IN POWER&rdquo; ON PAGE PS-4 OF THIS PRICING SUPPLEMENT.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Note Offering</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We are offering Trigger Autocallable Contingent Yield Notes linked to
the lesser performing of the common stock of Microsoft Corporation and the common stock of Oracle Corporation. The Notes will be issued
in minimum denominations equal to $1,000 and integral multiples of $1,000.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Underlying</B></FONT></TD>
    <TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Contingent Coupon Rate</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 15%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Initial Underlying Price*</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 18%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Coupon Barrier**</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 22%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Downside Threshold**</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 11%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>CUSIP / ISIN</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-bottom: #C7C8CA 1pt solid"><FONT STYLE="font-size: 10pt">Common stock of Microsoft Corporation (MSFT)</FONT></TD>
    <TD ROWSPAN="2" STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">20.30% per annum</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$506.00</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$328.90, which is 65.00% of the Initial Underlying Price</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; vertical-align: top; text-align: center"><FONT STYLE="font-size: 10pt">$328.90, which is 65.00% of the Initial Underlying Price</FONT></TD>
    <TD ROWSPAN="2" STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">06748V162 / US06748V1623</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #C7C8CA 1pt solid"><FONT STYLE="font-size: 10pt">Common stock of Oracle Corporation (ORCL)</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$240.83</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$156.54, which is 65.00% of the Initial Underlying Price</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$156.54, which is 65.00% of the Initial Underlying Price</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* The Initial Underlying Price of each Underlying is the Closing Price
of that Underlying on the Strike Date and is not the Closing Price of that Underlying on the Trade Date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">** Rounded to two decimal places</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>See &ldquo;Additional Information about Barclays Bank PLC and the
Notes&rdquo; on page PS-2 of this pricing supplement. The Notes will have the terms specified in the prospectus dated May 15, 2025, the
prospectus supplement dated May 15, 2025 and this pricing supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Neither the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
nor any state securities commission has approved or disapproved of the Notes or determined that this pricing supplement is truthful or
complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>We may use this pricing supplement in the initial sale of the Notes.
In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in market resale transactions in any
of the Notes after their initial sale. Unless we or our agent informs you otherwise in the confirmation of sale, this pricing supplement
is being used in a market resale transaction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>The Notes constitute our unsecured and unsubordinated obligations.
The Notes are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial Services Compensation Scheme or insured
by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit insurance agency of the United States, the
United Kingdom or any other jurisdiction.</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%; border-bottom: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 17%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Initial Issue Price<SUP>1</SUP></B></FONT></TD>
    <TD STYLE="width: 18%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Underwriting Discount</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 25%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #C7C8CA 1pt solid"><FONT STYLE="font-size: 10pt">Per Note</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$12.50</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$987.50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #C7C8CA 1pt solid"><FONT STYLE="font-size: 10pt">Total</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$3,000,000</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$37,500</FONT></TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$2,962,500</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><SUP>1</SUP> Our estimated value of the Notes on the Trade Date, based
on our internal pricing models, is $980.20 per Note. The estimated value is less than the initial issue price of the Notes. See &ldquo;Additional
Information Regarding Our Estimated Value of the Notes&rdquo; on page PS-3 of this pricing supplement.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>UBS Financial Services Inc.</B></FONT></TD>
    <TD STYLE="width: 50%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>Barclays Capital Inc.</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Additional Information about Barclays Bank PLC and the Notes</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read this pricing supplement together with the prospectus
dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term Notes, Series A,
of which these Notes are a part. This pricing supplement, together with the documents listed below, contains the terms of the Notes and
supersedes all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing
terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours.
You should carefully consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement
and &ldquo;Key Risks&rdquo; in this pricing supplement, as the Notes involve risks not associated with conventional debt securities. We
urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the terms set forth in this pricing supplement differ from those
set forth in the prospectus or prospectus supplement, the terms set forth herein will control.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>Prospectus supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><I>Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC. In this pricing supplement, &ldquo;Notes&rdquo;
refers to the Trigger Autocallable Contingent Yield Notes that are offered hereby, unless the context otherwise requires.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><I>
</I><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Additional Information Regarding Our Estimated Value of the Notes</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our internal pricing models take into account a number of variables
and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest rates
and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on variables, such
as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels at which our
benchmark debt securities trade in the secondary market. Our estimated value on the Trade Date is based on our internal funding rates.
Our estimated value of the Notes might be lower if such valuation were based on the levels at which our benchmark debt securities trade
in the secondary market.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our estimated value of the Notes on the Trade Date is less than the
initial issue price of the Notes. The difference between the initial issue price of the Notes and our estimated value of the Notes results
from several factors, including any sales commissions to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions,
discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates
expect to earn in connection with structuring the Notes, the estimated cost that we may incur in hedging our obligations under the Notes,
and estimated development and other costs that we may incur in connection with the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our estimated value on the Trade Date is not a prediction of the price
at which the Notes may trade in the secondary market, nor will it be the price at which Barclays Capital Inc. may buy or sell the Notes
in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or another affiliate of ours intends to
offer to purchase the Notes in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming that all relevant factors remain constant after the Trade Date,
the price at which Barclays Capital Inc. may initially buy or sell the Notes in the secondary market, if any, and the value that we may
initially use for customer account statements, if we provide any customer account statements at all, may exceed our estimated value on
the Trade Date for a temporary period expected to be approximately four months after the initial issue date of the Notes because, in our
discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our obligations under the Notes
and other costs in connection with the Notes that we will no longer expect to incur over the term of the Notes. We made such discretionary
election and determined this temporary reimbursement period on the basis of a number of factors, which may include the tenor of the Notes
and/or any agreement we may have with the distributors of the Notes. The amount of our estimated costs that we effectively reimburse to
investors in this way may not be allocated ratably throughout the reimbursement period, and we may discontinue such reimbursement at any
time or revise the duration of the reimbursement period after the initial issue date of the Notes based on changes in market conditions
and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>We urge you to read the &ldquo;Key Risks&rdquo; beginning on page
PS-11 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Consent to U.K. Bail-in Power</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Notwithstanding and to the exclusion of any other term of the Notes
or any other agreements, arrangements or understandings between us and any holder or beneficial owner of the Notes (or the trustee on
behalf of the holders of the Notes), by acquiring the Notes, each holder or beneficial owner of the Notes acknowledges, accepts, agrees
to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Under the U.K. Banking Act 2009, as amended, the relevant U.K. resolution
authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority is satisfied that the resolution
conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely to fail to satisfy the Financial
Services and Markets Act 2000 (the &ldquo;FSMA&rdquo;) threshold conditions for authorization to carry on certain regulated activities
(within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that is a European Economic Area (&ldquo;EEA&rdquo;)
or third country institution or investment firm, that the relevant EEA or third country relevant authority is satisfied that the resolution
conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The U.K. Bail-in Power includes any write-down, conversion, transfer,
modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of the principal amount
of, or interest on, or any other amounts payable on, the Notes; (ii) the conversion of all, or a portion, of the principal amount of,
or interest on, or any other amounts payable on, the Notes into shares or other securities or other obligations of Barclays Bank PLC or
another person (and the issue to, or conferral on, the holder or beneficial owner of the Notes of such shares, securities or obligations);
(iii) the cancellation of the Notes and/or (iv) the amendment or alteration of the maturity of the Notes, or the amendment of the amount
of interest or any other amounts due on the Notes, or the dates on which interest or any other amounts become payable, including by suspending
payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation of the terms of the Notes solely to
give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power. Each holder and beneficial owner of
the Notes further acknowledges and agrees that the rights of the holders or beneficial owners of the Notes are subject to, and will be
varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. For
the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders or beneficial owners of the Notes may have
at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K. resolution authority in breach of laws applicable
in England.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For more information, please see &ldquo;Key Risks&mdash;Risks Relating
to the Issuer&mdash;You may lose some or all of your investment if any U.K. bail-in power is exercised by the relevant U.K. resolution
authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating to the
Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail, including
the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely affect
the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms of the
securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo; in
the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Selected Purchase Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>The Notes may be appropriate for you if:</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You fully understand the risks inherent in an investment in the Notes, including the risk of loss of your entire principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate a loss of a significant portion or all of your principal amount and are willing to make an investment that may have
the full downside market risk of an investment in the Lesser Performing Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to accept the individual market risk of each Underlying and understand that any decline in the price of one
Underlying will not be offset or mitigated by a lesser decline or any potential increase in the price of the other Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe each Underlying is likely to close at or above its Coupon Barrier on the specified Observation Dates, and, if either Underlying
does not, you can tolerate receiving few or no Contingent Coupons over the term of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand that you may not receive a cash payment at maturity and are instead willing to accept delivery of the shares of the
Lesser Performing Underlying if the Final Underlying Price of the Lesser Performing Underlying is less than its Downside Threshold.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the Final Underlying Price of each Underlying is not likely to be less than its Downside Threshold and, if the Final Underlying
Price of either Underlying is less than its Downside Threshold, you can tolerate receiving shares of the Lesser Performing Underlying
at maturity expected to be worth significantly less than your principal amount and that may have no value at all.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and accept that you are not expected to participate in any appreciation of either Underlying, which may be significant,
and that your return potential on the Notes is limited to any Contingent Coupons paid on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You can tolerate fluctuations in the price of the Notes prior to maturity that may be similar to or exceed the downside fluctuations
in the prices of the Underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to hold Notes that will be called on the earliest monthly Observation Date on which the Closing Price of
each Underlying is greater than or equal to its Initial Underlying Price, and you are otherwise willing and able to hold the Notes to
maturity and accept that there may be little or no secondary market for the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not seek guaranteed current income from this investment, you are willing to accept the risk of contingent yield and you are
willing to forgo any dividends paid on the Underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You understand and are willing to accept the single equity risk associated with the Notes and understand and are willing to accept
the risks associated with each Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are willing and able to assume the credit risk of Barclays Bank PLC, as issuer of the Notes, for all payments under the Notes
and understand that if Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
Power, you might not receive any amounts due to you under the Notes, including any repayment of principal.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>The Notes may not be appropriate for you if: </B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not fully understand the risks inherent in an investment in the Notes, including the risk of loss of your entire principal
amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require an investment designed to provide a full return of principal at maturity, you cannot tolerate a loss of a significant
portion or all of your principal amount or you are not willing to make an investment that may have the full downside market risk of an
investment in the Lesser Performing Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unwilling or unable to accept the individual market risk of each Underlying or do not understand that any decline in the price
of one Underlying will not be offset or mitigated by a lesser decline or any potential increase in the price of the other Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not believe each Underlying is likely to close at or above its Coupon Barrier on the specified Observation Dates, or you cannot
tolerate receiving few or no Contingent Coupons over the term of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You require a cash payment at maturity and are not willing to accept delivery of the shares of the Lesser Performing Underlying if
the Final Underlying Price of the Lesser Performing Underlying is less than its Downside Threshold.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You believe the Final Underlying Price of either Underlying is likely to be less than its Downside Threshold, which could result in
a total loss of your principal amount, or you cannot tolerate receiving shares of the Lesser Performing Underlying at maturity expected
to be worth significantly less than your principal amount and that may have no value at all.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek an investment that participates in the full appreciation of either or both of the Underlyings and whose return is not limited
to any Contingent Coupons paid on the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You cannot tolerate fluctuations in the price of the Notes prior to maturity that may be similar to or exceed the downside fluctuations
in the prices of the Underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are unable or unwilling to hold Notes that will be called on the earliest monthly Observation Date on which the Closing Price
of each Underlying is greater than or equal to its Initial Underlying Price, or you are unable or unwilling to hold the Notes to maturity
and seek an investment for which there will be an active secondary market.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You seek guaranteed current income from your investment, you are unwilling to accept the risk of contingent yield or you prefer to
receive any dividends paid on the Underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You do not understand or are unwilling to accept the single equity risk associated with the Notes or do not understand or are not
willing to accept the risks associated with each Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You prefer the lower risk, and therefore accept the potentially lower returns, of fixed income investments with comparable maturities
and credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol">&uml;</FONT></TD><TD>You are not willing or are unable to assume the credit risk of Barclays Bank PLC, as issuer of the Notes, for all payments due to
you under the Notes, including any repayment of principal.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>The considerations identified above are not exhaustive. Whether or not the Notes are an appropriate investment for you will depend on your individual circumstances, and you should reach an investment decision only after you and your investment, legal, tax, accounting and other </B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">advisors <FONT STYLE="font-size: 10pt">have carefully considered the appropriateness of an investment in the Notes in light of your particular circumstances. You should also review carefully the &ldquo;Key Risks&rdquo; beginning on page PS-11 of this pricing supplement and the &ldquo;Risk </FONT></FONT></B></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Factors&rdquo; beginning on page S-9
of the prospectus supplement for risks related to an investment in the Notes. For more information about the Underlyings, please see the
sections titled &ldquo;Information about the Underlyings,&rdquo; &ldquo;Microsoft Corporation&rdquo; and &ldquo;</B></FONT><B>Oracle Corporation<FONT STYLE="font-size: 10pt">&rdquo;
below.</FONT></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Final Terms<SUP>1</SUP></B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; width: 20%; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Issuer:</FONT></TD>
    <TD STYLE="padding-top: 2pt; width: 80%; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Principal Amount:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">$1,000 per Note</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Term<SUP>2</SUP>:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Approximately 13 months, unless called earlier. See &ldquo;Key Dates&rdquo; on the cover of this pricing supplement.<SUP>2</SUP></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Reference Assets:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The common stock of Microsoft Corporation (Bloomberg ticker symbol &ldquo;MSFT&rdquo;) (the &ldquo;MSFT Underlying&rdquo;) and the common stock of Oracle Corporation (Bloomberg ticker symbol &ldquo;ORCL&rdquo;) (the &ldquo;ORCL Underlying&rdquo;) (each an &ldquo;Underlying&rdquo; and together the &ldquo;Underlyings&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Automatic Call Feature:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The Issuer will automatically call the Notes if the Closing Price of each Underlying on any monthly Observation Date is greater than or equal to its Initial Underlying Price. If the Notes are automatically called, the Issuer will pay the principal amount of your Notes <I>plus</I> the Contingent Coupon and any previously Unpaid Contingent Coupons due on the Coupon Payment Date that is also the Call Settlement Date, and no further amounts will be owed to you under the Notes.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Observation Dates<SUP>2</SUP>:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">As <FONT STYLE="background-color: white">set forth under the &ldquo;Observation Dates&rdquo; column of the table under &ldquo;Observation Dates/Coupon Payment Dates/Call Settlement Dates&rdquo; below</FONT>. The final Observation Date, December 11, 2026, is the &ldquo;Final Valuation Date.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Call Settlement Dates<SUP>2</SUP>:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt; background-color: white">As set forth under the &ldquo;Coupon Payment Dates/Call Settlement Dates&rdquo; column of the table under &ldquo;Observation Dates/Coupon Payment Dates/Call Settlement Dates&rdquo; below</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Contingent Coupon:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>If the Closing
    Price of each Underlying is greater than or equal to its Coupon Barrier on any Observation Date,</B></FONT> the Issuer will pay on the
    related Coupon Payment Date the Contingent Coupon applicable to that Observation Date plus all Contingent Coupons, if any, that would
    have been paid on a previous Coupon Payment Date had the Closing Price of each Underlying been greater than or equal to its Coupon Barrier
    on the related Observation Date and that have not been previously paid (&ldquo;Unpaid Contingent Coupons&rdquo;).</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>If the Closing
    Price of either Underlying is less than its Coupon Barrier on any Observation Date,</B></FONT> the Contingent Coupon applicable to that
    Observation Date will not be payable on the related Coupon Payment Date and the Issuer will not make any payment to you on that Coupon
    Payment Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If a Contingent Coupon is not paid on any Coupon Payment Date because
    the Closing Price of at least one Underlying is less than its Coupon Barrier on the related Observation Date, that Contingent Coupon will
    be paid as an Unpaid Contingent Coupon on a later Coupon Payment Date only if the Closing Price of each Underlying on the Observation
    Date related to that later Coupon Payment Date is greater than or equal to its Coupon Barrier. You will not receive any Unpaid Contingent
    Coupons if the Closing Price of at least one Underlying on each subsequent Observation Date is less than its Coupon Barrier.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Contingent Coupon is a fixed amount potentially payable monthly
    based on the per annum Contingent Coupon Rate.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon Barrier:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Underlying, a percentage of the Initial Underlying Price of that Underlying, as specified on the cover of this pricing supplement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Coupon Payment Dates<SUP>2</SUP>:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt; background-color: white">As set forth under the &ldquo;Coupon Payment Dates/Call Settlement Dates&rdquo; column of the table under &ldquo;Observation Dates/Coupon Payment Dates/Call Settlement Dates&rdquo; below</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Contingent Coupon Rate:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The Contingent Coupon Rate is 20.30% per annum. Accordingly, the Contingent Coupon with respect to each Observation Date is equal to $16.9167 per Note. <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Whether Contingent Coupons will be paid on the Notes will depend on the performance of the Underlyings.</B></FONT></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Payment at Maturity (per Note):</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>If the Notes
    are not automatically called and the Final Underlying Price of each Underlying is greater than or equal to its Downside Threshold (which
    equals its Coupon Barrier), </B></FONT>the Issuer will pay you a cash payment on the Maturity Date equal to $1,000 per Note <I>plus</I>
    the Contingent Coupon and any Unpaid Contingent Coupons due on the Coupon Payment Date that is also the Maturity Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>If the Notes
    are not automatically called and the Final Underlying Price of either Underlying is less than its Downside Threshold, </B></FONT>at maturity,
    the Issuer will deliver to you a number of shares of the Lesser Performing Underlying equal to its Share Delivery Amount (subject to adjustments)
    for each Note. If you receive shares of the Lesser Performing Underlying at maturity, the Issuer will pay cash in lieu of delivering any
    fractional shares of the Lesser Performing Underlying in an amount equal to that fraction times the Final Underlying Price of the Lesser
    Performing Underlying.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The Share Delivery Amount of the Lesser Performing Underlying
    is expected to be worth significantly less than the principal amount and may have no value at all. Accordingly, you may lose a significant
    portion or all of your principal at maturity, depending on how much the Lesser Performing Underlying declines, regardless of the performance
    of the other Underlying. Any payment on the Notes, including any repayment of principal, is subject to the creditworthiness of Barclays
    Bank PLC and is not guaranteed by any third party.</I></B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Underlying Return:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">With respect to each Underlying:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><U>Final Underlying Price &ndash; Initial Underlying
Price</U></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Initial Underlying Price</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Lesser Performing Underlying:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">The Underlying with the lower Underlying Return</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Downside Threshold:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Underlying, a percentage of the Initial Underlying Price of that Underlying, as specified on the cover of this pricing supplement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Share Delivery Amount: </FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">With respect to each Underlying, a number of shares of that Underlying
    equal to (1) the principal amount per Note of $1,000 divided by (2) its Initial Underlying Price (rounded to four decimal places)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Share Delivery Amount with respect to the common stock of Microsoft
Corporation is equal to 1.9763 shares per Note.&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Share Delivery Amount with respect to the common stock of Oracle
    Corporation is equal to 4.1523 shares per Note.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Initial Underlying Price:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Underlying, the Closing Price of that Underlying on the Strike Date, as specified on the cover of this pricing supplement. <I>The Initial Underlying Price for each Underlying is not the Closing Price of that Underlying on the Trade Date.</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Final Underlying Price:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Underlying, the Closing Price of that Underlying on the Final Valuation Date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Closing Price:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">With respect to each Underlying, Closing Price has the meaning set forth under &ldquo;Reference Assets&mdash;Equity Securities&mdash;Special Calculation Provisions&rdquo; in the prospectus supplement. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Calculation Agent:</FONT></TD>
    <TD STYLE="padding-top: 2pt; border-bottom: #C7C8CA 1pt solid; padding-right: 2pt; padding-bottom: 2pt"><FONT STYLE="font-size: 10pt">Barclays Bank PLC</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; color: White; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="font-size: 8pt; color: black"><SUP>1</SUP></FONT></TD><TD><FONT STYLE="font-size: 10pt; color: black">Terms
                                            used in this pricing supplement, but not defined herein, shall have the meanings ascribed
                                            to them in the prospectus supplement. The Underlyings and the terms of the Notes are subject
                                            to adjustment by the Calculation Agent and the Maturity Date may be accelerated, in each
                                            case under certain circumstances as set forth in the accompanying prospectus supplement.
                                            See &ldquo;Key Risks&mdash;Risks Relating to the Underlyings&rdquo; below.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 8pt Arial, Helvetica, Sans-Serif; color: White; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 13.7pt"><FONT STYLE="font-size: 8pt; color: black"><SUP>2</SUP></FONT></TD><TD><FONT STYLE="font-size: 10pt; color: black">Subject
                                            to postponement in certain circumstances, as described under &ldquo;Reference Assets&mdash;Equity
                                            Securities&mdash;Market Disruption Events for Securities with an Equity Security as a Reference
                                            Asset,&rdquo; &ldquo;Reference Assets&mdash;Least or Best Performing Reference Asset&mdash;Scheduled
                                            Trading Days and Market Disruption Events for Securities Linked to the Reference Asset with
                                            the Lowest or Highest Return in a Group of Two or More Equity Securities, Exchange-Traded
                                            Funds, Equity Indices and/or Equity Futures Indices&rdquo; and &ldquo;Terms of the Notes&mdash;Payment
                                            Dates&rdquo; in the accompanying prospectus supplement</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Investment Timeline</B></FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 4pt; vertical-align: top; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 4pt; width: 16%; background-color: #DEE7B3; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Strike Date:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: top; width: 11%">&nbsp;</TD>
    <TD STYLE="padding: 4pt; vertical-align: top; width: 68%">The Closing Price of each Underlying (the Initial Underlying Price) is observed and the Coupon Barrier, Downside Threshold and Share Delivery Amount of each Underlying are determined.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt">&nbsp;</TD>
    <TD STYLE="padding: 4pt; text-align: center"><IMG SRC="image_004.jpg" ALT=""></TD>
    <TD STYLE="padding: 4pt">&nbsp;</TD>
    <TD STYLE="padding: 4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding: 4pt; background-color: #DEE7B3; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Monthly:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding: 4pt; vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the Closing Price of each Underlying is greater than or equal to
    its Coupon Barrier on any Observation Date, the Issuer will pay you the Contingent Coupon applicable to that Observation Date <I>plus</I>
    any Unpaid Contingent Coupons.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">However, if the Closing Price of either Underlying is less than its
    Coupon Barrier on any Observation Date, no Contingent Coupon payment will be made with respect to that Observation Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Issuer will automatically call the Notes if the Closing Price of
    each Underlying on any monthly Observation Date is greater than or equal to its Initial Underlying Price. If the Notes are automatically
    called, the Issuer will pay the principal amount of your Notes plus the Contingent Coupon and any Unpaid Contingent Coupons due on the
    Coupon Payment Date that is also the Call Settlement Date, and no further amounts will be owed to you under the Notes.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 4pt; text-align: center"><IMG SRC="image_004.jpg" ALT=""></TD>
    <TD STYLE="padding: 4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 4pt; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding: 4pt; background-color: #DEE7B3; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Maturity Date:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: top">&nbsp;</TD>
    <TD STYLE="padding: 4pt; vertical-align: top">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The Final Underlying Price of each Underlying is determined as of the
    Final Valuation Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the Notes are not automatically called and the Final Underlying Price
    of each Underlying is greater than or equal to its Downside Threshold (which equals its Coupon Barrier), the Issuer will pay you a cash
    payment on the Maturity Date equal to $1,000 per Note plus the Contingent Coupon and any Unpaid Contingent Coupons due on the Coupon Payment
    Date that is also the Maturity Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the Notes are not automatically called and the Final Underlying Price
    of either Underlying is less than its Downside Threshold, at maturity, the Issuer will deliver to you a number of shares of the Lesser
    Performing Underlying equal to its Share Delivery Amount (subject to adjustments) for each Note. If you receive shares of the Lesser Performing
    Underlying at maturity, the Issuer will pay cash in lieu of delivering any fractional shares of the Lesser Performing Underlying in an
    amount equal to that fraction times the Final Underlying Price of the Lesser Performing Underlying.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><I>The Share Delivery Amount of the Lesser Performing Underlying
    is expected to be worth significantly less than the principal amount and may have no value at all. </I></B>Accordingly, you may lose a
    significant portion or all of your principal at maturity, depending on how much the Lesser Performing Underlying declines, regardless
    of the performance of the other Underlying.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the Notes involves significant risks. You may lose a
significant portion or all of your principal amount. You may receive few or no Contingent Coupons during the term of the Notes. You will
be exposed to the market risk of each Underlying and any decline in the price of one Underlying may negatively affect your return and
will not be offset or mitigated by a lesser decline or any potential increase in the price of the other Underlying. The Final Underlying
Price of each Underlying is observed relative to its Downside Threshold only on the Final Valuation Date, and the contingent repayment
of principal applies only if you hold the Notes to maturity. You may receive shares at maturity that are expected to be worth significantly
less than your principal amount and may have no value at all. Generally, the higher the Contingent Coupon Rate on a Note, the greater
the risk of loss on that Note. Your return potential on the Notes is expected to be limited to any Contingent Coupons paid on the Notes,
and you are not expected to participate in any appreciation of either Underlying. Any payment on the Notes, including any repayment of
principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC were
to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority,
you might not receive any amounts owed to you under the Notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Observation Dates/Coupon Payment Dates/Call Settlement Dates</FONT></B></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Observation Dates</B></FONT></TD>
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Coupon Payment Dates / Call Settlement Dates</B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">December 11, 2025</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">December 15, 2025</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">January 12, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">January 14, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">February 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">February 13, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">March 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">March 13, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">April 13, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">April 15, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">May 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">May 13, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">June 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">June 15, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">July 13, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">July 15, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">August 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">August 13, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">September 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">September 15, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">October 13, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">October 15, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">November 12, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">November 16, 2026</TD></TR>
  <TR>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">December 11, 2026</TD>
    <TD STYLE="border-bottom: #C7C8CA 1pt solid; text-align: center">December 16, 2026</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>

</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Key Risks</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the Notes involves significant risks. Investing in
the Notes is not equivalent to investing directly in either or both Underlyings. Some of the risks that apply to an investment in the
Notes are summarized below, but we urge you to read the more detailed explanation of risks relating to the Notes generally in the &ldquo;Risk
Factors&rdquo; section of the prospectus supplement. You should not purchase the Notes unless you understand and can bear the risks of
investing in the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><B>Risks Relating to the Notes Generally</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>You may lose a significant portion or all of your principal </B></FONT>&mdash;
The Notes differ from ordinary debt securities in that the Issuer will not necessarily pay the full principal amount of the Notes at maturity.
If the Notes are not automatically called, at maturity, the Issuer will pay you the principal amount of your Notes in cash only if the
Final Underlying Price of each Underlying is greater than or equal to its Downside Threshold and will make such payment only at maturity.
If the Notes are not automatically called and the Final Underlying Price of either Underlying is less than its Downside Threshold, the
Issuer will deliver to you a number of shares of the Lesser Performing Underlying equal to its Share Delivery Amount at maturity for each
Note that you own. If you receive shares of the Lesser Performing Underlying at maturity, their value on the Final Valuation Date will
be significantly less than the principal amount of the Notes, and they may have no value at all. The value of those shares may decrease
further between the Final Valuation Date and the Maturity Date. If you receive the Share Delivery Amount of the Lesser Performing Underlying,
the percentage loss on your initial investment, as of the Final Valuation Date, will be equal to the percentage decline of the price of
the Lesser Performing Underlying from its Initial Underlying Price to its Final Underlying Price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>You may not receive any Contingent Coupons</B></FONT> &mdash; The Issuer
will not necessarily make periodic coupon payments on the Notes. If the Closing Price of either Underlying on an Observation Date is less
than its Coupon Barrier, the Issuer will not pay you the Contingent Coupon applicable to that Observation Date or any Unpaid Contingent
Coupons. If a Contingent Coupon is not paid on any Coupon Payment Date because the Closing Price of at least one Underlying is less than
its Coupon Barrier on the related Observation Date, that Contingent Coupon will be paid as an Unpaid Contingent Coupon on a later Coupon
Payment Date only if the Closing Price of the other Underlying on the Observation Date related to that later Coupon Payment Date is greater
than or equal to its Coupon Barrier. You will not receive any Unpaid Contingent Coupons if the Closing Price of at least one Underlying
on each subsequent Observation Date is less than its Coupon Barrier. If the Closing Price of either Underlying is less than its Coupon
Barrier on each of the Observation Dates, the Issuer will not pay you any Contingent Coupons during the term of the Notes, and you will
not receive a positive return on your Notes. Generally, this non-payment of the Contingent Coupon coincides with a period of greater risk
of principal loss on your Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Your return potential on the Notes is expected to be limited to any Contingent
Coupons paid on the Notes, and you are not expected to participate in any appreciation of either Underlying</B>&nbsp;</FONT>&mdash; The
return potential of the Notes is expected to be limited to the pre-specified per annum Contingent Coupon Rate, regardless of any appreciation
of either Underlying. In addition, the total return on the Notes will vary based on the number and sequence of Observation Dates on which
the Closing Price of each Underlying has been greater than or equal to its Coupon Barrier prior to maturity or an automatic call. Further,
if the Notes are automatically called pursuant to the Automatic Call Feature, you will not receive Contingent Coupons or any other payment
in respect of any Observation Dates after the applicable Call Settlement Date. Because the Notes could be called as early as the first
Observation Date, the total return on the Notes could be minimal. If the Notes are not automatically called, you may be subject to the
decline in the price of the Lesser Performing Underlying even though you are not expected to participate in any appreciation of either
Underlying. As a result, the return on an investment in the Notes could be less than the return on a direct investment in either or both
Underlyings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Your potential return on the Notes will be different depending on the sequence
of Closing Prices on different Observation Dates</B></FONT> &mdash; Depending on the sequence in which the Closing Price of each Underlying
is greater than or equal to the Coupon Barrier on specific Observation Dates (if at all), you could receive a lesser or greater return
regardless of the number of Observation Dates on which the Closing Price of each Underlying is greater than or equal to its Coupon Barrier.
For example, if the Closing Price of any Underlying is less than its Coupon Barrier on each of the first twelve Observation Dates but
is greater than or equal to its Coupon Barrier on the Final Valuation Date, you will receive thirteen Contingent Coupons (twelve in the
form of Unpaid Contingent Coupons). However, if the Closing Price of each Underlying is greater than or equal to its Coupon Barrier on
each of the first two Observation Dates but on no subsequent Observation Dates, you will receive only two Contingent Coupons, even though
the Closing Price of each Underlying was greater than or equal to its Coupon Barrier on twice as many Observation Dates as in the previous
example.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>You are exposed to the market risk of each Underlying</B></FONT> &mdash;
Your return on the Notes is not linked to a basket consisting of the Underlyings. Rather, it will be contingent upon the independent performance
of each Underlying. Unlike an instrument with a return linked to a basket of underlying assets in which risk is mitigated and diversified
among all the components of the basket, you will be exposed to the risks related to each Underlying. Poor performance by either Underlying
over the term of the Notes may negatively affect your return and will not be offset or mitigated by any increases or lesser declines in
the price of the other Underlying. To receive any Contingent Coupons, the Closing Price of each Underlying must be greater than or equal
to its Coupon Barrier on the applicable Observation Date. In addition, if the Notes have not been automatically called prior to maturity
and the Final Underlying Price of either Underlying is less than its Downside Threshold, you will receive shares of the Lesser Performing
Underlying and will be exposed to the decline in the Lesser Performing Underlying. Accordingly, your investment is subject to the market
risk of each Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Because the Notes are linked to the Lesser Performing Underlying, you are
exposed to greater risks of no Contingent Coupons and sustaining a significant loss of principal at maturity than if the Notes were linked
to a single Underlying</B></FONT> &mdash; The risk that you will not receive any Contingent Coupons and lose a significant portion or
all of your principal amount in the Notes at maturity is greater if you invest in the Notes as opposed to substantially similar securities
that are linked to the performance of a single Underlying. With two Underlyings, it is more likely that the Closing Price of either Underlying
will be less than its Coupon Barrier on the specified Observation Dates or less than its Downside Threshold on the Final Valuation Date
and, therefore, it is more likely that you will not receive any Contingent Coupons and that you will suffer a significant loss of principal
at maturity. In addition, because the Closing Price of each Underlying must be greater than or equal to its Initial Underlying Price on
an Observation Date in order for the Notes to be automatically called prior to maturity, the Notes are less likely to be automatically
called on any Observation Date than if the Notes were linked to a single Underlying. Further, the performance of the Underlyings may not
be correlated or may be negatively correlated. The</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">lower the correlation between two Underlyings,
the greater the potential for one of those Underlyings to close below its Coupon Barrier or Downside Threshold on an Observation Date
or the Final Valuation Date, respectively. See &ldquo;Correlation of the Underlyings&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">It is impossible to predict what the correlation
between the Underlyings will be over the term of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">Although the correlation of the Underlyings&rsquo;
performance may change over the term of the Notes, the Contingent Coupon Rate is determined, in part, based on the correlation of the
Underlyings&rsquo; performance calculated using our internal models at the time when the terms of the Notes are finalized. A higher Contingent
Coupon Rate is generally associated with lower correlation of the Underlyings, which reflects a greater potential for missed Contingent
Coupons and for a loss of principal at maturity. The correlation referenced in setting the terms of the Notes is calculated using our
internal models and is not derived from the returns of the Underlyings over the period set forth under &ldquo;Correlation of the Underlyings&rdquo;
below. In addition, other factors and inputs other than correlation may impact how the terms of the Notes are set and the performance
of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>If the Notes are not automatically called, the payment at maturity, if
any, is based solely on the performance of the Lesser Performing Underlying </B></FONT>&mdash; If the Notes are not automatically called
pursuant to the Automatic Call Feature, the payment at maturity, if any, will be based solely on the performance of the Lesser Performing
Underlying. As a result, in the event that the Final Underlying Price of the Lesser Performing Underlying is less than its Downside Threshold,
you will receive shares of the Lesser Performing Underlying that are expected to be worth significantly less than your principal amount,
and may have no value at all, and you will not benefit from the performance of the other Underlying, even if the Final Underlying Price
of the other Underlying is greater than or equal to its Downside Threshold or Initial Underlying Price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Reinvestment risk</B></FONT> &mdash; If your Notes are automatically called
early, the holding period over which you would receive the per annum Contingent Coupon Rate could be as short as approximately one month.
There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes in a comparable investment with
a similar level of risk in the event the Notes are automatically called prior to the Maturity Date. The likelihood that the Notes will
be automatically called prior to the Maturity Date is highest earlier in their term. Generally, the longer the Notes remain outstanding,
the less likely it is that the Notes will be automatically called, due to the decline in the price of either or both of the Underlyings
that has caused the Notes not to be automatically called on an earlier Observation Date and the shorter time remaining for the price of
any such Underlying to increase to or above its Initial Underlying Price on a subsequent Observation Date. If the Notes are not automatically
called, you might be exposed to the full decline in the Lesser Performing Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Any payment or delivery on the Notes will be determined based on the Closing
Prices of the Underlyings on the dates specified</B></FONT> &mdash; Any payment or delivery on the Notes will be determined based on the
Closing Prices of the Underlyings on the dates specified. You will not benefit from any more favorable values of the Underlyings determined
at any other time.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Contingent repayment of principal applies only at maturity or upon any
automatic call</B></FONT> &mdash; You should be willing to hold your Notes to maturity or any automatic call. The market value of the
Notes may fluctuate between the date you purchase them and the Final Valuation Date. If you are able to sell your Notes prior to maturity
in the secondary market, if any, you may have to sell them at a loss relative to your principal amount even if at that time the price
of either or both of the Underlyings is greater than or equal to its Downside Threshold.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><B>You may receive cash at maturity in lieu of shares of the Lesser Performing Underlying</B> &mdash; If you receive shares of the
Lesser Performing Underlying at maturity, we will pay cash in lieu of delivering any fractional shares of that Underlying in an amount
equal to that fraction times the Final Underlying Price of the Lesser Performing Underlying. In addition, if, due to an event beyond our
control, we determine it is impossible, impracticable (including unduly burdensome) or illegal for us to deliver shares of the Lesser
Performing Underlying to you at maturity, we will pay the cash equivalent of its Share Delivery Amount (as determined by the Calculation
Agent in good faith and in a commercially reasonable manner) in lieu of delivering shares. See &ldquo;Terms of the Notes &mdash; Payment
at Maturity&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><B>If you receive shares of the Lesser Performing Underlying at maturity, those shares may be worth less on the Maturity Date than
their value based on the Final Underlying Price of the Lesser Performing Underlying</B> &mdash; If you receive shares of the Lesser Performing
Underlying at maturity, the value of those shares on the Maturity Date depends on the value of that Underlying on the Maturity Date rather
than its Final Underlying Price. The value of those shares may have declined further below the Final Underlying Price of the Lesser Performing
Underlying as of the Maturity Date and, as a result, the value of the payment at maturity may be less than if you had received on the
Maturity Date the cash value of those shares, calculated based on the Final Underlying Price of the Lesser Performing Underlying. We will
not make any adjustment to the Share Delivery Amount of the Lesser Performing Underlying to account for any fluctuations in the value
of the Lesser Performing Underlying and you will bear the risk of any decline in the value of the shares of the Lesser Performing Underlying
you receive at maturity below its Final Underlying Price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>A higher Contingent Coupon Rate and/or a lower Coupon Barrier and/or Downside
Threshold may reflect greater expected volatility of the Underlyings, which is generally associated with a greater risk of loss </B></FONT>&mdash;
Volatility is a measure of the degree of variation in the prices of the Underlyings over a period of time. The greater the expected volatilities
of the Underlyings at the time the terms of the Notes are set, the greater the expectation is at that time that you may not receive one
or more, or all, Contingent Coupon payments and that you may lose a significant portion or all of your principal at maturity. In addition,
the economic terms of the Notes, including the Contingent Coupon Rate, the Coupon Barrier and the Downside Threshold, are based, in part,
on the expected volatilities of the Underlyings at the time the terms of the Notes are set, where higher expected volatilities will generally
be reflected in a higher Contingent Coupon Rate than the fixed rate we would pay on conventional debt securities of the same maturity
and/or on otherwise comparable securities and/or a lower Coupon Barrier and/or a lower Downside Threshold as compared to otherwise comparable
securities. Accordingly, a higher Contingent Coupon Rate will generally be indicative of a greater risk of loss while a lower Coupon Barrier
or Downside Threshold does not necessarily indicate that the Notes have a greater likelihood of paying Contingent Coupon payments or returning
your principal at maturity. You should be willing to accept the downside market risk of each Underlying and the potential loss of a significant
portion or all of your principal at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Owning the Notes is not the same as owning either or both Underlyings</B></FONT>
&mdash; The return on your Notes may not reflect the return you would realize if you actually owned either or both Underlyings. As a holder
of the Notes, you will not have voting rights or rights to receive dividends or other distributions or other rights that holders of the
either Underlying would have.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>No assurance that the investment view implicit in the Notes will be successful</B></FONT>
&mdash; It is impossible to predict whether and the extent to which the price of either Underlying will rise or fall. There can be no
assurance that the price of either Underlying will not close below its Downside Threshold on the Final Valuation Date. The price of each
Underlying will be influenced by complex and interrelated political, economic, financial and other factors that affect that Underlying.
You should be willing to accept the downside risks associated with equities in general and each Underlying in particular, and the risk
of losing a significant portion or all of your principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Tax treatment </B></FONT>&mdash; Significant aspects of the tax treatment
of the Notes are uncertain. You should consult your tax advisor about your tax situation. See &ldquo;What Are the Tax Consequences of
an Investment in the Notes?&rdquo; on page PS-19 of this pricing supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: -0.2in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Credit of Issuer</B></FONT> &mdash; The Notes are unsecured and unsubordinated
debt obligations of the Issuer, Barclays Bank PLC, and are not, either directly or indirectly, an obligation of any third party. Any payment
to be made on the Notes, including any repayment of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations
as they come due and is not guaranteed by any third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC
may affect the market value of the Notes and, in the event Barclays Bank PLC were to default on its obligations, you might not receive
any amount owed to you under the terms of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>You may lose some or all of your investment if any U.K. Bail-in Power is
exercised by the relevant U.K. resolution authority </B></FONT>&mdash; Notwithstanding and to the exclusion of any other term of the Notes
or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the Notes (or
the trustee on behalf of the holders of the Notes), by acquiring the Notes, each holder or beneficial owner of the Notes acknowledges,
accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority as set
forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any U.K. Bail-in Power may be exercised
in such a manner as to result in you and other holders and beneficial owners of the Notes losing all or a part of the value of your investment
in the Notes or receiving a different security from the Notes, which may be worth significantly less than the Notes and which may have
significantly fewer protections than those typically afforded to debt securities. Moreover, the relevant U.K. resolution authority may
exercise the U.K. Bail-in Power without providing any advance notice to, or requiring the consent of, the holders and beneficial owners
of the Notes. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the Notes will not be a
default or an Event of Default (as each term is defined in the senior debt securities indenture) and the trustee will not be liable for
any action that the trustee takes, or abstains from taking, in either case, in accordance with the exercise of the U.K. Bail-in Power
by the relevant U.K. resolution authority with respect to the Notes. See &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement
as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action
in the event a bank or investment firm in the Group is failing or likely to fail, including the exercise by the relevant U.K. resolution
authority of a variety of statutory resolution powers, could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms of the securities, you have agreed to be bound by the exercise
of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>Risks Relating to the Underlyings</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Single equity risk</B></FONT> &mdash; The price of each Underlying can
rise or fall sharply due to factors specific to each Underlying and its issuer, such as stock price volatility, earnings, financial conditions,
corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors,
such as general stock market volatility and levels, interest rates and economic and political conditions. We urge you to review financial
and other information filed periodically with the SEC by the issuer of each Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Anti-dilution protection is limited, and the Calculation Agent has discretion
to make anti-dilution adjustments</B></FONT> &mdash; The Calculation Agent may in its sole discretion make adjustments affecting the amounts
payable on the Notes upon the occurrence of certain corporate events (such as stock splits or extraordinary or special dividends) that
the Calculation Agent determines have a diluting or concentrative effect on the theoretical value of an Underlying. However, the Calculation
Agent might not make such adjustments in response to all events that could affect an Underlying. The occurrence of any such event and
any adjustment made by the Calculation Agent (or a determination by the Calculation Agent not to make any adjustment) may adversely affect
the market price of, and any amounts payable on, the Notes. See &ldquo;Reference Assets&mdash;Equity Securities&mdash;Share Adjustments
Relating to Securities with an Equity Security as a Reference Asset&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Reorganization or other events could adversely affect the value of the
Notes or result in the Notes being accelerated</B></FONT> &mdash; Upon the occurrence of certain reorganization events or a nationalization,
expropriation, liquidation, bankruptcy, insolvency or de-listing of an Underlying, the Calculation Agent may replace that Underlying with
shares of another company identified as described in the prospectus supplement or, in some cases, with shares, cash or other assets distributed
to holders of that Underlying upon the occurrence of that event. In the alternative, the Calculation Agent may accelerate the Maturity
Date for a payment determined by the Calculation Agent or may make other changes to the terms of the Notes to account for the occurrence
of that event. Any decision by the Calculation Agent to replace an Underlying, to accelerate the Notes or to otherwise adjust the terms
of the Notes could adversely affect the value of, and any amount payable on, the Notes, perhaps significantly, and could result in a significantly
lower return on the Notes than if the Calculation Agent had made a different decision. See &ldquo;Reference Assets&mdash;Equity Securities&mdash;Share
Adjustments Relating to Securities with an Equity Security as a Reference Asset&rdquo; in the accompanying prospectus supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>Risks Relating to Conflicts of Interest</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Dealer incentives</B></FONT> &mdash; We, the Agents and affiliates of the
Agents act in various capacities with respect to the Notes. The Agents and various affiliates may act as a principal, agent or dealer
in connection with the Notes. Such Agents, including the sales representatives of</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">UBS Financial Services Inc., will derive
compensation from the distribution of the Notes and such compensation may serve as an incentive to sell these Notes instead of other investments.
We will pay compensation as specified on the cover of this pricing supplement to the Agents in connection with the distribution of the
Notes, and such compensation may be passed on to affiliates of the Agents or other third party distributors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Potentially inconsistent research, opinions or recommendations by Barclays
Capital Inc., UBS Financial Services Inc. or their respective affiliates</B></FONT> &mdash; Barclays Capital Inc., UBS Financial Services
Inc. or their respective affiliates and agents may publish research from time to time on financial markets and other matters that may
influence the value of the Notes, or express opinions or provide recommendations that are inconsistent with purchasing or holding the
Notes. Any research, opinions or recommendations expressed by Barclays Capital Inc., UBS Financial Services Inc. or their respective affiliates
or agents may not be consistent with each other and may be modified from time to time without notice. You should make your own independent
investigation of the merits of investing in the Notes and each Underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Potential Barclays Bank PLC impact on the prices of the Underlyings</B></FONT>
&mdash; Trading or transactions by Barclays Bank PLC or its affiliates in the Underlyings and/or over-the-counter options, futures or
other instruments with returns linked to the performance of either or both of the Underlyings, may adversely affect the price of either
Underlying and, therefore, the market value of the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>We and our affiliates may engage in various activities or make determinations
that could materially affect your Notes in various ways and create conflicts of interest</B></FONT> &mdash; We and our affiliates play
a variety of roles in connection with the issuance of the Notes, as described below. In performing these roles, our and our affiliates&rsquo;
economic interests are potentially adverse to your interests as an investor in the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">In connection with our normal business activities
and in connection with hedging our obligations under the Notes, we and our affiliates make markets in and trade various financial instruments
or products for our accounts and for the account of our clients and otherwise provide investment banking and other financial services
with respect to these financial instruments and products. These financial instruments and products may include securities, derivative
instruments or assets that may relate to an Underlying. In any such market making, trading and hedging activity, investment banking and
other financial services, we or our affiliates may take positions or take actions that are inconsistent with, or adverse to, the investment
objectives of the holders of the Notes. We and our affiliates have no obligation to take the needs of any buyer, seller or holder of the
Notes into account in conducting these activities. Such market making, trading and hedging activity, investment banking and other financial
services may negatively impact the value of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">In addition, the role played by Barclays
Capital Inc., as the agent for the Notes, could present significant conflicts of interest with the role of Barclays Bank PLC, as issuer
of the Notes. For example, Barclays Capital Inc. or its representatives may derive compensation or financial benefit from the distribution
of the Notes and such compensation or financial benefit may serve as an incentive to sell the Notes instead of other investments. Furthermore,
we and our affiliates establish the offering price of the Notes for initial sale to the public, and the offering price is not based upon
any independent verification or valuation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">In addition to the activities described
above, we will also act as the Calculation Agent for the Notes. As Calculation Agent, we will determine any values of the Underlyings
and make any other determinations necessary to calculate any payments on the Notes. In making these determinations, we may be required
to make discretionary judgments, including those described in the accompanying prospectus supplement and under &ldquo;&mdash;Risks Relating
to the Underlyings&rdquo; above. In making these discretionary judgments, our economic interests are potentially adverse to your interests
as an investor in the Notes, and any of these determinations may adversely affect any payments on the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.2in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in"><B>Risks Relating to the Estimated Value of the Notes
and the Secondary Market</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>There may be little or no secondary market for the Notes</B></FONT> &mdash;
The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make
a secondary market for the Notes but are not required to do so, and may discontinue any such secondary market making at any time, without
notice. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because
other dealers are not likely to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely
to depend on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the Notes.
The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your Notes to maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Many economic and market factors will impact the value of the Notes </B></FONT>&mdash;
Structured notes, including the Notes, can be thought of as securities that combine a debt instrument with one or more options or other
derivative instruments. As a result, the factors that influence the values of debt instruments and options or other derivative instruments
will also influence the terms and features of the Notes at issuance and their value in the secondary market. Accordingly, in addition
to the prices of the Underlyings on any day, the value of the Notes will be affected by a number of economic and market factors that may
either offset or magnify each other, including:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>the expected volatility of the Underlyings;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>correlation (or lack of correlation) of the Underlyings;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>the time to maturity of the Notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>the dividend rates on the Underlyings;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>interest and yield rates in the market generally;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>the existence of any Unpaid Contingent Coupons;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>supply and demand for the Notes;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>a variety of economic, financial, political, regulatory and judicial events; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD>our creditworthiness, including actual or anticipated downgrades in our credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>The estimated value of your Notes is lower than the initial issue price
of your Notes</B></FONT> &mdash; The estimated value of your Notes on the Trade Date is lower than the initial issue price of your Notes.
The difference between the initial issue price of your Notes and the estimated value of the Notes is a result of certain factors, such
as any sales commissions to be paid to Barclays Capital Inc. or another affiliate of ours, any selling concessions, discounts, commissions
or fees to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or any of our affiliates expect to earn in
connection with structuring the Notes, the estimated cost that we may incur in hedging our obligations under the Notes, and estimated
development and other costs that we may incur in connection with the Notes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>The estimated value of your Notes might be lower if such estimated value
were based on the levels at which our debt securities trade in the secondary market</B></FONT> &mdash; The estimated value of your Notes
on the Trade Date is based on a number of variables, including our internal funding rates. Our internal funding rates may vary from the
levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the estimated value referenced
above might be lower if such estimated value were based on the levels at which our benchmark debt securities trade in the secondary market.
Also, this difference in funding rate as well as certain factors, such as sales commissions, selling concessions, estimated costs and
profits mentioned below, reduces the economic terms of the Notes to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>The estimated value of the Notes is based on our internal pricing models,
which may prove to be inaccurate and may be different from the pricing models of other financial institutions</B></FONT> &mdash; The estimated
value of your Notes on the Trade Date is based on our internal pricing models, which take into account a number of variables and are based
on a number of subjective assumptions, which may or may not materialize. These variables and assumptions are not evaluated or verified
on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo; pricing models and the
methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may
be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of your Notes may be materially different
from the estimated value of the Notes determined by reference to our internal pricing models.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>The estimated value of your Notes is not a prediction of the prices at
which you may sell your Notes in the secondary market, if any, and such secondary market prices, if any, will likely be lower than the
initial issue price of your Notes and may be lower than the estimated value of your Notes</B></FONT> &mdash; The estimated value of the
Notes will not be a prediction of the prices at which Barclays Capital Inc., other affiliates of ours or third parties may be willing
to purchase the Notes from you in secondary market transactions (if they are willing to purchase, which they are not obligated to do).
The price at which you may be able to sell your Notes in the secondary market at any time will be influenced by many factors that cannot
be predicted, such as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than our estimated
value of the Notes. Further, as secondary market prices of your Notes take into account the levels at which our debt securities trade
in the secondary market, and do not take into account our various costs related to the Notes such as fees, commissions, discounts, and
the costs of hedging our obligations under the Notes, secondary market prices of your Notes will likely be lower than the initial issue
price of your Notes. As a result, the price at which Barclays Capital Inc., other affiliates of ours or third parties may be willing to
purchase the Notes from you in secondary market transactions, if any, will likely be lower than the price you paid for your Notes, and
any sale prior to the Maturity Date could result in a substantial loss to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&uml;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>The temporary price at which we may initially buy the Notes in the secondary
market and the value we may initially use for customer account statements, if we provide any customer account statements at all, may not
be indicative of future prices of your Notes</B></FONT> &mdash; Assuming that all relevant factors remain constant after the Trade Date,
the price at which Barclays Capital Inc. may initially buy or sell the Notes in the secondary market (if Barclays Capital Inc. makes a
market in the Notes, which it is not obligated to do) and the value that we may initially use for customer account statements, if we provide
any customer account statements at all, may exceed our estimated value of the Notes on the Trade Date, as well as the secondary market
value of the Notes, for a temporary period after the initial issue date of the Notes. The price at which Barclays Capital Inc. may initially
buy or sell the Notes in the secondary market and the value that we may initially use for customer account statements may not be indicative
of future prices of your Notes. Please see &ldquo;Additional Information Regarding Our Estimated Value of the Notes&rdquo; on page PS-3
for further information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>

</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Hypothetical Examples</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Hypothetical terms only. Actual terms may vary.
See the cover page for actual offering terms.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below illustrate the payment upon a call or at maturity
for a $1,000 principal amount Note on a hypothetical offering of the Notes under various scenarios, with the assumptions set forth below.*
You should not take these examples as an indication or assurance of the expected performance of the Notes. The examples below do not take
into account any tax consequences from investing in the Notes. Numbers appearing in the examples below have been rounded for ease of analysis.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%">Term:</TD>
    <TD STYLE="width: 62%">Approximately 13 months (unless called earlier)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Contingent Coupon Rate:</TD>
    <TD>20.30% per annum (or 1.6917% per month)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Contingent Coupon:</TD>
    <TD>$16.9167 per month</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Hypothetical Initial Underlying Price:</TD>
    <TD>$100.00 for the MSFT Underlying and $100.00 for the ORCL Underlying</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Hypothetical Coupon Barrier:</TD>
    <TD>$65.00 for the MSFT Underlying and $65.00 for the ORCL Underlying (which, with respect to each Underlying, is 65.00% of the hypothetical Initial Underlying Price of that Underlying)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Hypothetical Downside Threshold:</TD>
    <TD>$65.00 for the MSFT Underlying and $65.00 for the ORCL Underlying (which, with respect to each Underlying, is 65.00% of the hypothetical Initial Underlying Price of that Underlying)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Hypothetical Share Delivery Amount:</TD>
    <TD>10 shares per Note for the MSFT Underlying ($1,000 / hypothetical Initial Underlying Price of $100.00) and 10 shares per Note for the ORCL Underlying (which, with respect to each Underlying, is $1,000 / hypothetical Initial Underlying Price of that Underlying of $100.00)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Observation Dates:</TD>
    <TD>Monthly, as set forth under &ldquo;Final Terms&rdquo; and &ldquo;Observation Dates/Coupon Payment Dates/Call Settlement Dates&rdquo; in this pricing supplement</TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt">*</TD><TD>Terms used for purposes of these hypothetical examples do not represent the actual Initial Underlying Prices, Coupon Barriers, Downside
Thresholds or Share Delivery Amounts. The hypothetical Initial Underlying Prices of $100.00 for the MSFT Underlying and $100.00 for the
ORCL Underlying have been chosen for illustrative purposes only and do not represent the actual Initial Underlying Prices for the Underlyings.
The actual Initial Underlying Price, Coupon Barrier and Downside Threshold of each Underlying are set forth on the cover of this pricing
supplement, and the actual Share Delivery Amount of each Underlying is indicated under &ldquo;Final Terms&mdash;Share Delivery Amount&rdquo;
in this pricing supplement. For historical Closing Prices of the Underlyings, please see the historical information set forth under the
sections titled &ldquo;Microsoft Corporation&rdquo; and &ldquo;Oracle Corporation&rdquo; below. We cannot predict the Closing Price of
either Underlying on any day during the term of the Notes, including on any Observation Date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are purely hypothetical. These examples are intended
to illustrate (a) under what circumstances the Notes will be subject to an automatic call, (b) how the payment of a Contingent Coupon
with respect to any Observation Date will depend on whether the Closing Price of either Underlying on that Observation Date is less than
its Coupon Barrier, (c) how the value of the payment at maturity on the Notes will depend on whether the Final Underlying Price of either
Underlying is less than its Downside Threshold and (d) how the total return on the Notes may be less than the total return on a direct
investment in either or both Underlyings in certain scenarios. The &ldquo;total return&rdquo; as used in this pricing supplement is the
number, expressed as a percentage, that results from comparing the total payments per Note over the term of the Notes to the $1,000 principal
amount.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; Notes Are Automatically Called on the First Observation
Date</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Observation Date</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Closing Price</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 60%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Payment (per Note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>First Observation Date</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $110.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $115.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of each Underlying at or above its Initial Underlying Price; Notes are automatically called; Issuer pays principal <I>plus</I> Contingent Coupon of $16.9167 on Call Settlement Date.</TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; width: 38%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Payments (per Note):</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 31%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Payment on Call Settlement Date:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 29%">$1,016.9167 ($1,000.00 + $16.9167)</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">$1,016.9167</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Return:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">1.6917%</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the Closing Price of each Underlying is greater than or equal
to its Initial Underlying Price on the first Observation Date, the Notes are automatically called on that Observation Date. The Issuer
will pay you on the Call Settlement Date $1,016.9167 per Note, which is equal to your principal amount <I>plus</I> the Contingent Coupon
due on the Coupon Payment Date that is also the Call Settlement Date, for a total return of 1.6917% on the Notes. No further amounts will
be owed to you under the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; Notes Are NOT Automatically Called and the Final
Underlying Price of Each Underlying Is At or Above Its Downside Threshold</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Observation Date</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Closing Price</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 60%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Payment (per Note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>First Observation Date</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $115.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $95.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of at least one Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of each Underlying at or above its Coupon Barrier; Issuer pays Contingent Coupon of $16.9167 on first Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Second Observation Date</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $80.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $75.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of each Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of each Underlying at or above its Coupon Barrier; Issuer pays Contingent Coupon of $16.9167 on second Coupon Payment Date.</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">Third Observation Date</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $85.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $50.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Closing Price of each Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of ORCL Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent Coupon on third Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Fourth to Twelfth Observation Dates</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Various (at least one Underlying below Coupon Barrier)</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Closing Price of at least one Underlying below its Initial Underlying
    Price; Notes NOT automatically called. Closing Price of at least one Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent
    Coupon on any of the fourth to twelfth Coupon Payment Dates.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Thirteenth Observation Date (the Final Valuation Date)</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $105.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $70.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Closing Price of ORCL Underlying below its Initial Underlying Price;
    Notes NOT automatically called. Final Underlying Price of each Underlying at or above its Downside Threshold and Coupon Barrier; Issuer
    pays principal <I>plus</I> Contingent Coupon of $186.0837 (reflecting Contingent Coupon for Final Valuation Date and Unpaid Contingent
    Coupons for third through twelfth Observation Dates) on Maturity Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Payments (per Note):</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Payment at Maturity:</B></FONT></TD>
    <TD STYLE="width: 29%">$1,186.0837 ($1,000.00 + $186.0837)</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Prior Contingent Coupons:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">$33.8334 ($16.9167 &times; 2)</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">$1,219.9171</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Return:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom">21.9917%</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the Closing Price of at least one Underlying was less than its
Initial Underlying Price on each Observation Date, the Notes are not automatically called. Because the Final Underlying Price of each
Underlying is greater than or equal to its Downside Threshold and Coupon Barrier, the Issuer will pay you on the Maturity Date $1,186.0837
per Note, which is equal to your principal amount <I>plus</I> the Contingent Coupon for the Final Valuation Date and the Unpaid Contingent
Coupons for the third through twelfth Observation Dates.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In addition, because the Closing Price of each Underlying was greater
than or equal to its Coupon Barrier on the first and second Observation Dates, the Issuer will pay the Contingent Coupon of $16.9167 on
each of the first and second Coupon Payment Dates. Because the Closing Price of at least one Underlying was less than its Coupon Barrier
on the third through twelfth Observation Dates, the Issuer will not pay any Contingent Coupon on the Coupon Payment Dates following those
Observation Dates; however, because the Closing Price of each Underlying on the Final Valuation Date is greater than its Coupon Barrier,
the Contingent Coupon that would have been paid on each of the third through twelfth Coupon Payment Dates had the Closing Price of each
Underlying been greater than or equal to its Coupon Barrier on the third through twelfth Observation Dates will be paid on the Maturity
Date. Accordingly, the Issuer will have paid a total of $1,219.9171 per Note for a total return of 21.9917% on the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 3 &mdash; Notes Are NOT Automatically Called and the Final
Underlying Price of At Least One Underlying Is Below Its Downside Threshold</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Observation Date</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Closing Price</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 60%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Payment (per Note)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>First Observation Date</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $45.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $50.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of each Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of each Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent Coupon on first Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Second Observation Date</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $105.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $50.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of ORCL Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of ORCL Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent Coupon on second Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Third Observation Date</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $40.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $50.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>Closing Price of each Underlying below its Initial Underlying Price; Notes NOT automatically called. Closing Price of each Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent Coupon on third Coupon Payment Date.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Fourth to Twelfth Observation Dates</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">Various (at least one Underlying below Coupon Barrier)</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Closing Price of at least one Underlying below its Initial Underlying
    Price; Notes NOT automatically called. Closing Price of at least one Underlying below its Coupon Barrier; Issuer DOES NOT pay Contingent
    Coupon on any of the fourth to twelfth Coupon Payment Dates.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Thirteenth Observation Date (the Final Valuation Date) </TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">MSFT Underlying: $40.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">ORCL Underlying: $110.00</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P></TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Closing Price of MSFT Underlying below its Initial Underlying Price;
    Notes NOT automatically called. Closing Price of MSFT Underlying below its Downside Threshold and Coupon Barrier; Issuer DOES NOT pay
    Contingent Coupon on Maturity Date; Issuer delivers the Share Delivery Amount with respect to the MSFT Underlying (with fractional shares
    paid in cash) on the Maturity Date.</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 38%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Payments (per Note):</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 31%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Value of Shares Received (as of Final Valuation Date*):</B></FONT></TD>
    <TD STYLE="width: 29%">$400.00 (10 shares &times; $40.00)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Value of Payment at Maturity: </B></FONT></TD>
    <TD>$400.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Prior Contingent Coupons:</B></FONT></TD>
    <TD>$0.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total:</B></FONT></TD>
    <TD>$400.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Total Return:</B></FONT></TD>
    <TD>-60.00%</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the Closing Price of at least one Underlying is less than its
Initial Underlying Price on each Observation Date, the Notes are not automatically called. Because the Final Underlying Price of at least
one Underlying is less than its Downside Threshold, the Issuer will deliver to you on the Maturity Date the number of shares of the Lesser
Performing Underlying equal to its Share Delivery Amount for every Note you hold and will pay cash based on the Final Underlying Price
of the Lesser Performing Underlying for any fractional shares included in the Share Delivery Amount. Accordingly, the Issuer will have
delivered shares and paid cash with a total value of $400.00 per Note, for a total return of -60.00% on the Notes, as of the Final Valuation
Date*.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In addition, because the Closing Price of at least one Underlying is
less than its Coupon Barrier on each Observation Date, the Issuer will not pay any Contingent Coupons over the term of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">* The value of shares received at maturity and the total return on the
Notes at that time depends on the value of the Lesser Performing Underlying on the Maturity Date, rather than the Final Valuation Date,
and is expected to be worth significantly less than the principal amount or may have no value at all.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
<FONT STYLE="color: white"><B>

</B></FONT></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">What Are the Tax Consequences of an Investment in the Notes?</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should review carefully the sections in the accompanying prospectus
supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as
Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences
to Non-U.S. Holders.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In determining our reporting responsibilities, if any, we intend to
treat (i) the Notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent coupons and (ii) any
Contingent Coupons as ordinary income, as described in the section entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax
Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward or Derivative Contracts with Associated Coupons&rdquo; in the accompanying
prospectus supplement. Our special tax counsel, Davis Polk &amp; Wardwell LLP, has advised that it believes this treatment to be reasonable,
but that there are other reasonable treatments that the Internal Revenue Service (the &ldquo;IRS&rdquo;) or a court may adopt.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Sale, exchange or redemption of a Note.</I> Assuming the treatment
described above is respected, upon a sale or exchange of the Notes (including redemption upon an automatic call or at maturity), you should
recognize capital gain or loss equal to the difference between the amount realized on the sale or exchange and your tax basis in the Notes,
which should equal the amount you paid to acquire the Notes (assuming Contingent Coupons are properly treated as ordinary income, consistent
with the position referred to above). This gain or loss should be short-term capital gain or loss unless you hold the Notes for more than
one year, in which case the gain or loss should be long-term capital gain or loss, whether or not you are an initial purchaser of the
Notes at the issue price. The deductibility of capital losses is subject to limitations. If you sell your Notes between the time your
right to a Contingent Coupon is fixed and the time it is paid, it is likely that you will be treated as receiving ordinary income equal
to the Contingent Coupon. Although uncertain, it is possible that proceeds received from the sale or exchange of your Notes prior to an
Observation Date but that can be attributed to an expected Contingent Coupon payment could be treated as ordinary income. You should consult
your tax advisor regarding this issue.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As noted above, there are other reasonable treatments that the IRS or
a court may adopt, in which case the timing and character of any income or loss on the Notes could be materially affected. In addition,
in 2007 the U.S. Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of &ldquo;prepaid
forward contracts&rdquo; and similar instruments. The notice focuses in particular on whether to require investors in these instruments
to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of
income or loss with respect to these instruments and the relevance of factors such as the nature of the underlying property to which the
instruments are linked. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations
or other guidance promulgated after consideration of these issues could materially affect the tax consequences of an investment in the
Notes, possibly with retroactive effect. You should consult your tax advisor regarding the U.S. federal income tax consequences of an
investment in the Notes, including possible alternative treatments and the issues presented by this notice.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><I>Non-U.S. holders.</I> Insofar as we have responsibility as a withholding
agent, we do not currently intend to treat Contingent Coupon payments to non-U.S. holders (as defined in the accompanying prospectus supplement)
as subject to U.S. withholding tax. However, non-U.S. holders should in any event expect to be required to provide appropriate Forms W-8
or other documentation in order to establish an exemption from backup withholding, as described under the heading &ldquo;&mdash;Information
Reporting and Backup Withholding&rdquo; in the accompanying prospectus supplement. If any withholding is required, we will not be required
to pay any additional amounts with respect to amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Treasury regulations under Section 871(m) generally impose a withholding
tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent IRS notice excludes
from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo; with respect
to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying Security&rdquo;).
Based on our determination that the Notes do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations, our special
tax counsel is of the opinion that these regulations should not apply to the Notes with regard to non-U.S. holders. Our determination
is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application may depend
on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security. You should
consult your tax advisor regarding the potential application of Section 871(m) to the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Information about the Underlyings</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Included below are brief descriptions of the issuers of each of the
Underlyings. This information has been obtained from publicly available sources. We obtained the Closing Price information for the Underlyings
from Bloomberg Professional<SUP>&reg;</SUP> service (&ldquo;Bloomberg&rdquo;) without independent verification. You should not take the
historical prices of the Underlyings as an indication of future performance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We urge you to read the following section in the accompanying prospectus
supplement: &ldquo;Reference Assets&mdash;Equity Securities&mdash;Reference Asset Issuer and Reference Asset Information.&rdquo; Companies
with securities registered under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;), are required to file
financial and other information specified by the SEC periodically. Such information can be reviewed electronically through a website maintained
by the SEC at http://www.sec.gov. Information filed with the SEC by the issuer of each Underlying can be located by reference to its SEC
file number provided below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information from outside sources is not incorporated by reference in,
and should not be considered part of, this pricing supplement or any accompanying prospectus or prospectus supplement. We have not independently
verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>

</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Microsoft Corporation</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">According to publicly available information, Microsoft Corporation is
a technology company that develops and supports software, services, devices and solutions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information filed by Microsoft Corporation with the SEC under the Exchange
Act can be located by reference to its SEC file number: 001-37845. The MSFT Underlying is listed on The Nasdaq Stock Market under the
ticker symbol &ldquo;MSFT.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Historical Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performance of the MSFT
Underlying from January 2, 2015 through November 10, 2025, based on the daily Closing Prices of the MSFT Underlying. The Closing Price
of the MSFT Underlying on November 10, 2025 was $506.00. The dotted line represents the Coupon Barrier and the Downside Threshold of $328.90,
which is equal to 65.00% of the Initial Underlying Price of the MSFT Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the Closing Prices of the MSFT Underlying from Bloomberg,
without independent verification. Historical performance of the MSFT Underlying should not be taken as an indication of future performance.
Future performance of the MSFT Underlying may differ significantly from historical performance, and no assurance can be given as to the
Closing Price of the MSFT Underlying during the term of the Notes, including on any Observation Date. We cannot give you assurance that
the performance of the MSFT Underlying will not result in a loss of your principal amount<I>. The Closing Prices below may reflect adjustments
in response to certain corporate actions, such as stock splits, public offerings, mergers and acquisitions, spin-offs, extraordinary dividends,
delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.jpg" ALT=""><B></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>

</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Oracle Corporation</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">According to publicly available information, Oracle Corporation provides
products and services that address enterprise information technology needs.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Information filed by Oracle Corporation with the SEC under the Exchange
Act can be located by reference to its SEC file number: 001-35992. The ORCL Underlying is listed on the New York Stock Exchange under
the ticker symbol &ldquo;ORCL.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Historical Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performance of the ORCL
Underlying from January 2, 2015 through November 10, 2025, based on the daily Closing Prices of the ORCL Underlying. The Closing Price
of the ORCL Underlying on November 10, 2025 was $240.83. The dotted line represents the Coupon Barrier and the Downside Threshold of $156.54,
which is equal to 65.00% of the Initial Underlying Price of the ORCL Underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the Closing Prices of the ORCL Underlying from Bloomberg,
without independent verification. Historical performance of the ORCL Underlying should not be taken as an indication of future performance.
Future performance of the ORCL Underlying may differ significantly from historical performance, and no assurance can be given as to the
Closing Price of the ORCL Underlying during the term of the Notes, including on any Observation Date. We cannot give you assurance that
the performance of the ORCL Underlying will not result in a loss of your principal amount. <I>The Closing Prices below may reflect adjustments
in response to certain corporate actions, such as stock splits, public offerings, mergers and acquisitions, spin-offs, extraordinary dividends,
delistings and bankruptcy.</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_002.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Correlation of the Underlyings </FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth the historical performances of the MSFT
Underlying and the ORCL Underlying from January 2, 2015 through November 10, 2025, based on the daily Closing Prices of the Underlyings.
For comparison purposes, each Underlying has been normalized to have a Closing Price of $100.00 on January 2, 2015 by dividing the Closing
Price of that Underlying on each day by the Closing Price of that Underlying on January 2, 2015 and multiplying by $100.00.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We obtained the Closing Prices used to determine the normalized Closing
Prices set forth below from Bloomberg, without independent verification. Historical performance of the Underlyings should not be taken
as an indication of future performance. Future performance of the Underlyings may differ significantly from historical performance, and
no assurance can be given as to the Closing Prices of the Underlyings during the term of the Notes, including on any Observation Date.
We cannot give you assurance that the performances of the Underlyings will not result in a loss of your principal amount.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE AND CORRELATION OF THE UNDERLYINGS
ARE NOT INDICATIVE OF FUTURE PERFORMANCE OR CORRELATION.</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The correlation of a pair of Underlyings represents a statistical measurement
of the degree to which the returns of those Underlyings were similar to each other over a given period in terms of timing and direction.
The correlation between a pair of Underlyings is scaled from 1.0 to -1.0, with 1.0 indicating perfect positive correlation (i.e., the
value of both Underlyings are increasing together or decreasing together and the ratio of their returns has been constant), 0 indicating
no correlation (i.e., there is no statistical relationship between the returns of that pair of Underlyings) and -1.0 indicating perfect
negative correlation (i.e., as the value of one Underlying increases, the value of the other Underlying decreases and the ratio of their
returns has been constant).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closer the relationship of the returns of a pair of Underlyings
over a given period, the more positively correlated those Underlyings are. The graph above illustrates the historical performance of each
Underlying relative to each other over the time period shown and provides an indication of how close the relative performance of each
Underlying has historically been to the other Underlying. However, the graph does not provide a precise measurement of the correlation
of the Underlyings. Moreover, any historical correlation of the Underlyings is not indicative of the degree of correlation of the Underlyings,
if any, that will be experienced over the term of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The lower (or more negative) the correlation between the Underlyings,
the less likely it is that the Underlyings will move in the same direction at the same time and, therefore, the greater the potential
for one of the Underlyings to close below its Coupon Barrier or Downside Threshold on any Observation Date or the Final Valuation Date,
respectively. This is because the less positively correlated the Underlyings are, the greater the likelihood that at least one of the
Underlyings will decrease in value. However, even if the Underlyings have a higher positive correlation, one or both of the Underlyings
might close below its Coupon Barrier or Downside Threshold on any Observation Date or the Final Valuation Date, respectively, as both
of the Underlyings may decrease in value together.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Although the correlation of the Underlyings&rsquo; performance may change
over the term of the Notes, the Contingent Coupon Rate is determined, in part, based on the correlation of the Underlyings&rsquo; performance
calculated using our internal models at the time when the terms of the Notes are finalized. A higher Contingent Coupon Rate is generally
associated with lower correlation of the Underlyings, which reflects a greater potential for missed Contingent Coupons and for a loss
of principal at maturity. The correlation referenced in setting the terms of the Notes is calculated using our internal models and is
not derived from the returns of the Underlyings over the period set forth above. In addition, other factors and inputs other than correlation
may impact how the terms of the Notes are set and the performance of the Notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B><I>
</I></B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Supplemental Plan of Distribution</FONT></B></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have agreed to sell to Barclays Capital Inc. and UBS Financial Services
Inc., together the &ldquo;Agents,&rdquo; and the Agents have agreed to purchase, all of the Notes at the initial issue price less the
underwriting discount indicated on the cover of this pricing supplement. UBS Financial Services Inc. may allow a concession not in excess
of the underwriting discount set forth on the cover of this pricing supplement to its affiliates.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We or our affiliates have entered or will enter into swap agreements
or related hedge transactions with one of our other affiliates or unaffiliated counterparties in connection with the sale of the Notes
and the Agents and/or an affiliate may earn additional income as a result of payments pursuant to the swap, or related hedge transactions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have agreed to indemnify the Agents against liabilities, including
certain liabilities under the Securities Act of 1933, as amended, or to contribute to payments that the Agents may be required to make
relating to these liabilities as described in the prospectus and the prospectus supplement. We have agreed that UBS Financial Services
Inc. may sell all or a part of the Notes that it purchases from us to its affiliates at the price that is indicated on the cover of this
pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #788D41; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white"><B>Validity of the Notes</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special United States
products counsel to Barclays Bank PLC, when the Notes offered by this pricing supplement have been issued by Barclays Bank PLC pursuant
to the indenture, the trustee has made, in accordance with instructions from Barclays Bank PLC, appropriate entries or notations in its
records relating to the master global note that represents such Notes (the &ldquo;master note&rdquo;), and such Notes have been delivered
against payment as contemplated herein, such Notes will be valid and binding obligations of Barclays Bank PLC, enforceable in accordance
with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&rsquo; rights generally, concepts
of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing
and the lack of bad faith) and possible judicial or regulatory actions or application giving effect to governmental actions or foreign
laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance,
fraudulent transfer or similar provision of applicable law on the conclusions expressed above or (ii) the validity, legally binding effect
or enforceability of any provision that permits holders to collect any portion of the stated principal amount upon acceleration of the
Notes to the extent determined to constitute unearned interest. This opinion is given as of the date hereof and is limited to the laws
of the State of New York. Insofar as this opinion involves matters governed by English law, Davis Polk &amp; Wardwell LLP has relied,
with Barclays Bank PLC&rsquo;s permission, on the opinion of Davis Polk &amp; Wardwell London LLP, dated as of May 15, 2025, filed as
an exhibit to the Registration Statement on Form F-3ASR by Barclays Bank PLC on May 15, 2025, and this opinion is subject to the same
assumptions, qualifications and limitations as set forth in such opinion of Davis Polk &amp; Wardwell London LLP. In addition, this opinion
is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery of the indenture and its authentication
of the master note and the validity, binding nature and enforceability of the indenture with respect to the trustee, all as stated in
the opinion of Davis Polk &amp; Wardwell LLP, dated May 15, 2025, which has been filed as an exhibit to the Registration Statement referred
to above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp237315_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-13</xbrli:startDate>
          <xbrli:endDate>2025-11-13</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-13</xbrli:startDate>
          <xbrli:endDate>2025-11-13</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">3,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">3,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">414.30</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">3,000,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">414.30</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">414.30</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">3,000,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  B !0# 2(  A$! Q$!_\0
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IP]K6O:EJ<6+BVF;3[<D<$ @NX]C\F#Z9H ]MHHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %' FP# 2(  A$! Q$!_\0
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MIO\ X+Y/_CU:M% &5]GU_P#Z">F_^"^3_P"/4?9]?_Z">F_^"^3_ ./5JT4
M97V?7_\ H)Z;_P""^3_X]1]GU_\ Z">F_P#@OD_^/5JT4 97V?7_ /H)Z;_X
M+Y/_ (]1]GU__H)Z;_X+Y/\ X]6K10!E?9]?_P"@GIO_ (+Y/_CU'V?7_P#H
M)Z;_ ."^3_X]6K10!E?9]?\ ^@GIO_@OD_\ CU'V?7_^@GIO_@OD_P#CU:M%
M &5]GU__ *">F_\ @OD_^/4?9]?_ .@GIO\ X+Y/_CU:M% &5]GU_P#Z">F_
M^"^3_P"/4?9]?_Z">F_^"^3_ ./5JT4 97V?7_\ H)Z;_P""^3_X]1]GU_\
MZ">F_P#@OD_^/5JT4 97V?7_ /H)Z;_X+Y/_ (]1]GU__H)Z;_X+Y/\ X]6K
M10!E?9]?_P"@GIO_ (+Y/_CU'V?7_P#H)Z;_ ."^3_X]6K10!E?9]?\ ^@GI
MO_@OD_\ CU'V?7_^@GIO_@OD_P#CU:M% &5]GU__ *">F_\ @OD_^/4?9]?_
M .@GIO\ X+Y/_CU:M% &5]GU_P#Z">F_^"^3_P"/4?9]?_Z">F_^"^3_ ./5
MJT4 97V?7_\ H)Z;_P""^3_X]1]GU_\ Z">F_P#@OD_^/5JT4 97V?7_ /H)
MZ;_X+Y/_ (]1]GU__H)Z;_X+Y/\ X]6K10!E?9]?_P"@GIO_ (+Y/_CU'V?7
M_P#H)Z;_ ."^3_X]6K10!E?9]?\ ^@GIO_@OD_\ CU'V?7_^@GIO_@OD_P#C
MU:M% &5]GU__ *">F_\ @OD_^/4?9]?_ .@GIO\ X+Y/_CU:M% &5]GU_P#Z
M">F_^"^3_P"/4?9]?_Z">F_^"^3_ ./5JT4 97V?7_\ H)Z;_P""^3_X]1]G
MU_\ Z">F_P#@OD_^/5JT4 97V?7_ /H)Z;_X+Y/_ (]1]GU__H)Z;_X+Y/\
MX]6K10!E?9]?_P"@GIO_ (+Y/_CU'V?7_P#H)Z;_ ."^3_X]6K10!E?9]?\
M^@GIO_@OD_\ CU'V?7_^@GIO_@OD_P#CU:M% &5]GU__ *">F_\ @OD_^/4?
M9]?_ .@GIO\ X+Y/_CU:M% &5]GU_P#Z">F_^"^3_P"/4?9]?_Z">F_^"^3_
M ./5JT4 97V?7_\ H)Z;_P""^3_X]1]GU_\ Z">F_P#@OD_^/5JT4 97V?7_
M /H)Z;_X+Y/_ (]1]GU__H)Z;_X+Y/\ X]6K10!E?9]?_P"@GIO_ (+Y/_CU
M'V?7_P#H)Z;_ ."^3_X]6K10!E?9]?\ ^@GIO_@OD_\ CU'V?7_^@GIO_@OD
M_P#CU:M% &5]GU__ *"6F_\ @OD_^/58T:[EU#0]/O9P@EN+:.5P@(7<R@G
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MT1J7#E-FW!;(P&W#CM2ZE\/]8N]&\46L;6GFZGK<=_ 6D./*5D/S''!^4\4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1K2?^?9_^_P#)_P#%4?\
M"-:3_P ^S_\ ?^3_ .*K6HH R?\ A&M)_P"?9_\ O_)_\51_PC6D_P#/L_\
MW_D_^*K6HH R?^$:TG_GV?\ [_R?_%4?\(UI/_/L_P#W_D_^*K6HH R?^$:T
MG_GV?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1K2?^?9_^_P#)_P#%
M4?\ "-:3_P ^S_\ ?^3_ .*K6HH R?\ A&M)_P"?9_\ O_)_\51_PC6D_P#/
ML_\ W_D_^*K6HH R?^$:TG_GV?\ [_R?_%4?\(UI/_/L_P#W_D_^*K6HH R?
M^$:TG_GV?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1K2?^?9_^_P#)
M_P#%4?\ "-:3_P ^S_\ ?^3_ .*K6HH R?\ A&M)_P"?9_\ O_)_\51_PC6D
M_P#/L_\ W_D_^*K6HH R?^$:TG_GV?\ [_R?_%4?\(UI/_/L_P#W_D_^*K6H
MH R?^$:TG_GV?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1K2?^?9_^
M_P#)_P#%4?\ "-:3_P ^S_\ ?^3_ .*K6HH R?\ A&M)_P"?9_\ O_)_\51_
MPC6D_P#/L_\ W_D_^*K6HH R?^$:TG_GV?\ [_R?_%4?\(UI/_/L_P#W_D_^
M*K6HH R?^$:TG_GV?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1K2?^
M?9_^_P#)_P#%4?\ "-:3_P ^S_\ ?^3_ .*K6HH R?\ A&M)_P"?9_\ O_)_
M\51_PC6D_P#/L_\ W_D_^*K6HH R?^$:TG_GV?\ [_R?_%4?\(UI/_/L_P#W
M_D_^*K6HH R?^$:TG_GV?_O_ "?_ !5'_"-:3_S[/_W_ )/_ (JM:B@#)_X1
MK2?^?9_^_P#)_P#%51U?1;&QT_[3;1/',DT6UA,YQF10>I]":Z2LKQ'_ ,@5
M_P#KM#_Z-2@#5HHHH **** "LKPS_P BIH__ %XP_P#H K5K*\,_\BIH_P#U
MXP_^@"@ M_\ D:]0_P"O&U_]#GK5K*M_^1KU#_KQM?\ T.>M6@ HHHH ****
M "L?Q9_R)NN?]@^?_P!%M6Q6/XL_Y$W7/^P?/_Z+:@#0L?\ D'VW_7)?Y"K%
M5['_ )!]M_UR7^0JQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_?\ P_&C^T+['_(&N?\ O[%Z9_O^O'_UJT:* ,XZA? '&C7)Z_\ +6+GC/\
M?]>/PH.H7HSC1KDXSC][%ST_V^_]*T:* ,XW]Z"<:/<G&?\ EK%SSC^_^/X4
M?;[W/_('N?\ O[%ZX_O^G/\ ]>M&B@#.%_>DC.CW(Z?\M8N.<?W_ $YH%_>G
M&='N1G&?WL7'7_;[?UK1HH SAJ%Z0,Z-<C./^6L7'&?[_P"'XT?VA>X_Y US
M_P!_8O3/]_UX_P#K5HT4 9QU"] .-&N3U_Y:Q<\9_O\ KQ0=0O1G&C7)QG'[
MV+GI_M]_Z5HT4 9QO[T$XT>Y.,_\M8N>?]_\?PH^WWN?^0/<_P#?V+UQ_?\
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M_P#T6U &A8_\@^V_ZY+_ "%6*KV/_(/MO^N2_P A5B@ HHHH **** "BBB@
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M% !65X9_Y%31_P#KQA_] %:M97AG_D5-'_Z\8?\ T 4 %O\ \C7J'_7C:_\
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M *]_7/\ >]: -&BLX:'IX((BDXQ_RW?US_>]:!H6GKC$4G&,?OY.V<?Q>YH
MT:*SAH6GKC$4G&,?OY.P('\7O1_86GXQY4GI_KY/3'][TH T:*SCH6GD$>5)
MSG_EO)Z8_O>E!T+3VSF*3G.?W\G?&?XO84 :-%9QT/3VSF*3G.?W\G<@G^+V
MH_L/3R<^5)_W_?US_>]: -&BLX:'IX(/E2<?]-W]<_WO6@:%IZXQ%)QC'[^3
MMG'\7N: -&BLX:%IZXQ%)QC'[^3L"!_%[FC^PM/QCRI/^_\ )Z8_O>E &C16
M<="T\@CRI.?^F\GIC^]Z4'0M/;.8I.<Y_?R=\ _Q>PH T:\T\5?$5M"\575O
M;0S7%O;6Z13#:3&LI(<G([K$')'7BNW?2=* E9@V$!,G^D/\N<$Y^;CH#6/H
M?A/2YM-:[O+(O/?.UQ()96;AF9E!YQD*V/IQR*[\'.C2<JE>',MK;;_Y)$2N
M]$<]90:;X M]'NK:%VO=3L1;)%(<>=/A"B]/ERQ;)]2:Z[P[X=;0[B^F:=9?
MM2P9 7&&2,*Q)[Y()_&HM9\'Z=J,-LR6X-Q;7,4T3R2,=FV16;&2<$@$5IC0
M]/!&(I.,8_?R=B2/XO<U>(QCJT[W]Z5^:_D[Q_ %&S//]?6YTS5=6;2MQ^QL
M]U<1G)#+<A0WMG(9A[*:N^+?!NH:G::G DKR64S6JVUM$H#*2T:2N6/HBGVY
MS741^$])2ZNIVA=S<K&KJ\K$;44@#KR/F/7UJW_86GX_U4G_ '_D],?WO2M?
M[3E!PE36L;:]]OR:T?87)?<R(_!-A+X,_P"$=OU$D;@F5X_E+R9R'X[]#^ J
M32#?:7K<NDW$"_8I=\UO=!OOG"?(1G@CYS] />M,Z%IY!'E2<_\ 3>3TQ_>]
M*YOQKH]O::3!J<$4Q6QNDN)T29]SQ9 =5YZD >E84JU2O-TINZDWOTD^J^:2
M^8VDM4='J?\ R$-&_P"OMO\ T1+6E7G&BWUCXFU73;8VWE7,"FYO%6Y=MA:-
ME\L8;A@QY_W?>NV.AZ>23Y4G/_3=_7/][UK'$T9T7&G-6:7ZL:=]4:-97B/_
M ) K_P#7:'_T:E2?V'IX.?*D]?\ 7OZY_O>M9VMZ396VEF6*-PZRPX)E<_\
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M?^0?;?\ 7)?Y"K%5['_D'VW_ %R7^0JQ0 4444 %%%% !1110 4444 %%%%
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MGWDGQ'O9+=&CD:!O,8,G!*X+XZ<<BNB\<>"_%7B/5H;G1?&=SHULD(1K>(,
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MUQZ>G- O-3.,Z4HZ9_TE>.N>WT_.@#S.P^&7CZUU"WGE^)=]+''(K.C>8P8
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M(W+Y"J5;DXSCC.1F";P3;RQ%!JVI1M+&\=U(IB+7(9BY+DQG;\S$X3:.<8P
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M#GD#G/I@UGKX[MC:K,VD:E&9?):VCE,$9N%E)",I:4*N=OW7*MD@8R0*FL?
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M?^N?IS^GO6A10!GB?5LC.GVG;/\ I;>O_7/TY_3WH$^K\9T^T'3.+QN.N?\
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M^<:?:'KC-XW/3'_+/ZUH44 9YGU?G&GVAZXS>-SR,?\ +/ZT>?JV?^0?:?\
M@6WK_P!<_3G]/>M"B@#/\_5LC.GVG_@6WK_US].?T]Z!/J_&=/M!TSB\;CKG
M_EG]*T** ,\3ZOQG3[0=,XO&XZY_Y9_2D\_5\#.GVG_@8WI_US]>/U]JT:*
M,[S]7P?^)?:?^!C>G_7/UX_7VI3/J_.-/M#UQF\;G@8_Y9_6M"B@#/,^K\XT
M^T/7&;QN>F/^6?UH,^K9.-/M/_ MO7_KGZ<_I[UH44 9_GZMG_D'VG_@6WK_
M -<_3G]/>LW6YM2;2B)[.VCC,L.YDN2Y'[U>VP9[=^Y].>BK*\1_\@5_^NT/
M_HU* -6BBB@ HHHH *RO#/\ R*FC_P#7C#_Z *U:RO#/_(J:/_UXP_\ H H
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MT-<T.RU[3)[.[MX)&DA>..26(.8BRXW#/?\ PH M6/\ R#[;_KDO\A5BN?\
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M6I//%:V\D\\BQQ1J7=V. H')- %>_P!2M=/-O'/<0PS74GDVPE.!)+M)"Y_
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MVL$=U<&]N( R)=2H!)L)X!/K@ $\9QFI[Z^M]-LY+NZ<I$@YP"Q)[  <DD\
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MU&#4HM;#Q;<7&I:=%);2QB,VFL*?F+J#P%/.T;BK XR201D9KIK:SBA=IS#
M+N55$\T<04R$#OWQZ9)Q0!9KFO$&ND&?3]+F=[^V>%[R&W0-.ENQY>-2/F./
M0'OQG%7]<UA]'2"86XN(BQ,Z(W[U8P.71.K[<C('./7I66EA9>*$FU6QADL+
MD3![/4UP6EPH7>!WC(&W:?O 9]#0 GA+6K^[O+S3=1\R0QCS[6>5!'*T)9E
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MVZU=G\107=TFG76F-<7HNEDLD@D#1S(K<3*_  7'S \@\<Y&4TOP[>RZG?\
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MR:*$W]K+&Z7*.$-A(1Q-$<?/$P#':?F!W*<@Y'H&GZ?;Z9:^1;1)&I8R,$&
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M<[M_H$FI>(+*^N+J(VEIN9+?[.-Y9E*D&3/*$')7') YXK;5510J@!0,  <
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %97AG_D5-'_Z\8?_ $ 5JUE>&?\ D5-'_P"O&'_T
M 4 ,G@U2#7;B]LK>SGAFMH8B)KEHF5D:0G@1MD8<=^QI_P!HU_\ Z!NF_P#@
MPD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\
MH&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]H
MU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^
M,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;
M_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\
MZ!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44
M 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#
M"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF
M_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC
M7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_X
MS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@
MPD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\
MH&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]H
MU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^
M,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;
M_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\
MZ!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44
M 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#
M"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF
M_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC
M7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_X
MS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@
MPD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\
MH&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]H
MU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^
M,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;
M_P"#"3_XS1]HU_\ Z!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS1]HU_\
MZ!NF_P#@PD_^,T44 'VC7_\ H&Z;_P"#"3_XS4^C6DNGZ%I]E.4,UO;1Q.4)
/*[E4 X) R,CT%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %' FP# 2(  A$! Q$!_\0
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M_CU:M% &5]GU_P#Z">F_^"^3_P"/4?9]?_Z">F_^"^3_ ./5JT4 97V?7_\
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M_P"@GIO_ (+Y/_CU'V?7_P#H)Z;_ ."^3_X]6K10!E?9]?\ ^@GIO_@OD_\
MCU'V?7_^@GIO_@OD_P#CU:M% &5]GU__ *">F_\ @OD_^/4?9]?_ .@GIO\
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M:?JFLV%M+;W4<I-O'*)"#N0A6VD8 Z<CTJEHGP]U/2]8\-WLLUK)]CN+ZZO
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#*\3?\BIK'_7C-_Z :U:RO$W_
M "*FL?\ 7C-_Z :U: ,K2?\ D):[_P!?R_\ I/#6K65I/_(2UW_K^7_TGAK5
MH **** ,_5[2[O+=8[9[8J<B6&YBWI(I'?N,'FL>'PO=Q6MEI[7Z265NUNYD
M:/$Q:$@@;AU!*CKR!D5U%% '-Z;X9FLM0M&DN8GL[!YWM46,A\RDD[CG'RAF
M P.<TWQK;*='^UK+<I*L]M'^[N)$4JTZ*P*A@#D,1R*Z:L#QI_R+3_\ 7W:?
M^E$= %G_ (1K2?\ GV?_ +_R?_%4?\(UI/\ S[/_ -_Y/_BJUJ* ,G_A&M)_
MY]G_ ._\G_Q5'_"-:3_S[/\ ]_Y/_BJUJ* ,G_A&M)_Y]G_[_P G_P 51_PC
M6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?_O\ R?\ Q5'_  C6D_\ /L__ '_D
M_P#BJUJ* ,G_ (1K2?\ GV?_ +_R?_%4?\(UI/\ S[/_ -_Y/_BJUJ* ,G_A
M&M)_Y]G_ ._\G_Q5'_"-:3_S[/\ ]_Y/_BJUJ* ,G_A&M)_Y]G_[_P G_P 5
M1_PC6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?_O\ R?\ Q5'_  C6D_\ /L__
M '_D_P#BJUJ* ,G_ (1K2?\ GV?_ +_R?_%4?\(UI/\ S[/_ -_Y/_BJUJ*
M,G_A&M)_Y]G_ ._\G_Q5'_"-:3_S[/\ ]_Y/_BJUJ* ,G_A&M)_Y]G_[_P G
M_P 51_PC6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?_O\ R?\ Q5'_  C6D_\
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MM)_Y]G_[_P G_P 51_PC6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?_O\ R?\
MQ5'_  C6D_\ /L__ '_D_P#BJUJ* ,G_ (1K2?\ GV?_ +_R?_%4?\(UI/\
MS[/_ -_Y/_BJUJ* ,G_A&M)_Y]G_ ._\G_Q5'_"-:3_S[/\ ]_Y/_BJUJ* ,
MG_A&M)_Y]G_[_P G_P 51_PC6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?_O\
MR?\ Q5'_  C6D_\ /L__ '_D_P#BJUJ* ,G_ (1K2?\ GV?_ +_R?_%4?\(U
MI/\ S[/_ -_Y/_BJUJ* ,G_A&M)_Y]G_ ._\G_Q5'_"-:3_S[/\ ]_Y/_BJU
MJ* ,G_A&M)_Y]G_[_P G_P 51_PC6D_\^S_]_P"3_P"*K6HH R?^$:TG_GV?
M_O\ R?\ Q55+S2K/3KW2Y;2-XW:[",?-<Y4HYQ@GV%;=S=V]G&LES,D2,VT,
MYP"?3]#5#6?]?I/_ %_+_P"@/3L[7 U:***0!1110!E>)O\ D5-8_P"O&;_T
M UJUE>)O^14UC_KQF_\ 0#6K0!E:3_R$M=_Z_E_])X:U:RM)_P"0EKO_ %_+
M_P"D\-:M !1110 45EZY>7MC8FXM! %C#/-)*COM4#@!$Y8DX'7CKSTK"3QA
M=S1_;4M[=+* VB7*%M[EIPA^1@<87S%['//2@#L:P/&G_(M/_P!?=I_Z41U7
MTWQ)=7>HV0FA@%GJ,EQ';A,^8AB)Y8YP=P5CP!C@<U)XVFB3P\R-(BN;JU(4
ML 2/M$= '1T5";JW'6>+C_;%'VJW_P">\7_?8H FHJ'[5;_\]XO^^Q]*/M5N
M?^6\7_?8H FHJ'[5;G_EXB_[[%'VNV_Y^(O^^Q0!-14/VNV_Y^(O^^Q]:/M=
ML/\ EXB_[[% $U%0_:K<=;B+_OL4?:K?_GO%_P!]B@":BH?M5O\ \]XO^^Q]
M*/M5O_SWB_[[% $U%0_:K<]+B+_OL4?:[;_GXB_[[% $U%0_:[;_ )^(O^^Q
M]:/M=L/^7B+_ +[% $U%0_:K<=;B+_OL4?:K<?\ +>+_ +[% $U%0_:K?_GO
M%_WV/I1]JM_^>\7_ 'V* )J*A^U6YZ7$7_?8H^UVW_/Q%_WV* )J*A^UVW_/
MQ%_WV/K1]KMO^?B+_OL4 345#]JMQUN(O^^Q1]JM_P#GO%_WV* )J*A^U6__
M #WB_P"^Q]*/M5O_ ,]XO^^Q0!-14/VJW/2XB_[[%'VNV/\ R\1?]]B@":BH
M?M=M_P _$7_?8^M'VNV_Y^(O^^Q0!-14/VJW'6XB_P"^Q1]JMQ_RWB_[[% $
MU%0_:K?_ )[Q?]]CZ4?:K?\ Y[Q?]]B@":BH?M5N>EQ%_P!]BC[7;'_EXB_[
M[% $U%0_:[;_ )^(O^^Q]:/M=M_S\1?]]B@":BH?M5N/^7B+_OL4?:K<?\MX
MO^^Q0!-14/VJW_Y[Q?\ ?8^E'VJW_P">\7_?8H FHJ'[5;GI<1?]]BC[7;'_
M )>(O^^Q0!-14/VNV_Y^(O\ OL?6C[7;?\_$7_?8H FHJ'[5;CK<1?\ ?8H^
MU6X_Y;Q?]]B@":BH?M5O_P ]XO\ OL?2C[5;_P#/>+_OL4 345#]JMSTN(O^
M^Q1]KMS_ ,O$7_?8H FHJ'[7;?\ /Q%_WV/K1]KMO^?B+_OL4 345#]JMQ_R
M\1?]]BC[5;C_ )>(O^^Q0!-14/VJW_Y[Q?\ ?8^E'VJW_P">\7_?8H FHJ'[
M5;GI<1?]]BC[5;G_ )>(O^^Q0!RGQ,F^S^%#-_SSD+_E&YK;U=@T^DX(.+Y<
M^W[MZY'XPZC'!X#D:)XY"\ZQ8##HZ,N?R.:UH[B*>_\ W<BM_P 3S& <](,5
MZ<Z5\#"IYR_]M(3]YHZZBBBO,+"BBB@#*\3?\BIK'_7C-_Z :U:RO$W_ "*F
ML?\ 7C-_Z :U: ,K2?\ D):[_P!?R_\ I/#6K65I/_(2UW_K^7_TGAK5H **
M** *>H6+WJQ^5?7-I)&20\!'((P00P(/XCBLF'P;I]L84MYKF*U3R3);!@4E
M:+&QF)&<\#.",X&:Z*B@#&LO#=M8Z@ETD\[I"TK6]NY79"9#ER,#)R<]2<9.
M*I>.+.UFT$SRVT+S+<VJK(T8+ &XCX!].3^==-6!XT_Y%I_^ONT_]*(Z -,Z
M5IQSG3[4YSG,*\YZ]O84ITK3CG-A:\]?W*^N?3UYJW10!4_LK3O^?"U_[\KZ
MY]/7F@:5IPQBPM1C&/W*]CGT]:MT4 4QI6G#&-/M1C&,0KQCIV]S0-)TT8QI
M]KQ_TQ7TQZ>G%7** *?]DZ;_ - ^U_[\KZ8]/3B@Z3IISG3[4YSG]RO<8]/2
MKE% %,Z5IQSG3[4YSG,*\YZ]O84ITK3CG-A:G/7]ROKGT]>:MT4 5/[*T[_G
MPM?^_*^N?3UYH&E:<,8L+48QC]ROKGT]:MT4 4QI6G#&-/M1C&,0KQCIV]S0
M-)TT8QI]J,=/W*^F/3TXJY10!3_LG3?^@?:_]^5],>GIQ0=)TTYSI]J<]?W*
M^F/3TJY10!3.E:<<YT^U.<YS"O.>O;V%*=*TXYS86ISU_<KZY]/6K=% %3^R
MM._Y\+7_ +\KZY]/7F@:5IPQBPM1CI^Y7USZ>M6Z* *8TK3AC&GVHQC'[E>,
M=.WN:!I.FC&-/M1C&/W*^F/3TJY10!3_ +)TW_H'VO\ WY7TQZ>G%!TG33G.
MGVISU_<KZ8]/3BKE% %,Z5IQSG3[4YSG,*\YZ]O84ITK3CG-A:G.<_N5]<^G
MK5NB@"I_96G?\^%K_P!^5]<^GKS0-*TX8Q86HQT_<KZY]/7FK=% %,:5IPQC
M3[48QC]RO&.G;W- TG3AC&GVHQC'[E>PQZ>E7** *?\ 9.F_] ^U_P"_*^F/
M3TXH.DZ:<YT^UYZ_N5],>GIQ5RB@"F=*TXYSI]J<YSF%><]>WL*4Z5IQSFPM
M3G.?W*]SGT]:MT4 5/[*T[_GPM?^_*^N?3UYH&E:<,8L+7CI^Y7USZ>O-6Z*
M *8TK3AC&GVHQC'[E>,=.WN:!I.FC&-/M1C&/W*]A@=O0U<HH I_V3IO_0/M
M?^_*^F/3TXH.DZ:<YT^UY_Z8KZ8]/3BKE% %,Z5IQSG3[4YSG,*\YZ]O84IT
MK3CG-A:G.<_N5[G)[>U6Z* *G]E:=_SX6O\ WY7USZ>O- TK3AC%A:\?],5]
M<^GKS5NB@"F-*TX8QI]J,8QB%>,=.WN:!I.G#&-/M1C&/W*]N!V]ZN44 4_[
M)TW_ *!]K_WY7TQZ>G%']DZ:<YT^UY_Z8KZ8]/3BKE% %,Z5IQSG3[4YSG,*
M\YZ]O84ITK3CG-A:G.<_N5[\GM[5;HH J?V5IW_/A:_]^5]<^GKS1_96G#I8
M6O'_ $Q7USZ>O-6Z* *8TK3AC%A:C&,?N5XQT[>YH&DZ<,8T^U&,8_<KVX';
MW-7** *?]DZ;_P! ^U_[\KZ8]/3BC^R=-/\ S#[7G_IBOICT].*N44 4SI6G
M'.=/M3G.<PKSGKV]A2G2M..<V%J<YS^Y7OR>WL*MT4 5/[*T[_GPM?\ OROK
MGT]>:/[*TX?\N%K_ -^5]<^GKS5NB@"F-*TX8Q86HQC&(5XQT[>YH&DZ<,8T
M^U&,8_<KVZ=O<U<HH XCX@Z!IEYX=2W>S@2,R,Y,:!3\D,C#D?[HK-\)7%GJ
M5G%J=I%&(YO$$QB<1A3Y>U@O3M@"NO\ $5LEZEA:2$B.>X:)B.N&AE!Q^=<?
MI<)T/Q;#X8MT4:?:?998VQ@F3RG5S^/!KV(24\!*GU7O>5KZ_.]ON,W\5STJ
MBBBO'- HHHH RO$W_(J:Q_UXS?\ H!K5K*\3?\BIK'_7C-_Z :U: ,K2?^0E
MKO\ U_+_ .D\-:M96D_\A+7?^OY?_2>&M6@ HJI>ZE;V&P3>8SOG9'%$TCMC
MK@*":CM-8M;R<0*MQ#,02J7$#Q%@/3<!F@"_16-XBN[RRLEGM[NVL[="6N+B
M9"Y4 ?*%3C<2V!U^F2:Q[77-;-W9S:K;RV%F\=LKD0*5,TGWE)+;@-Q5> <'
MJ: .QK \:?\ (M/_ -?=I_Z41U2TKQ!J%UJ.G23F(VFI27,<<*QD-#Y1.TEL
M\Y"G/ Y(Q3O'6HVUOHGV:1G$KW%JX C8C N(^X&.QH ZJBLYM<T]<YDEXSG_
M $>3MC/\/N*#KE@"09)>,_\ +"3L<?W?4T :-%9W]N6&<>9+Z?ZB3UQ_=]:!
MKE@2,22\XQ^XD[G']WVH T:*SAKNGMC$DO.,?Z/)WSC^'V- UW3R 1)+SC_E
MWD[C/]WT% &C16=_;NGXSYDOK_Q[R>F?[OI0==T\ YDEXSG_ $>3L,_W?0T
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M/]WTH.NZ> 29)>,Y_P!'D[#/]WT- &C16<==T]<YDEXSG_1Y.V,_P^XH.N6
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MWD],_P!WTH T:*SCKNGKG,DO&<_Z/)VQG^'W%!US3U)S)+QG/^CR=B!_=]Z
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M,]&AYQC_ *:=\_I0=1N!G_B3WQQGHT//./\ GI^/X4 :%%9_]HW&?^01??\
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MF@ZC<X/_ !)[X]?XH?3/_/3\/K[<T :%%9YU&Y&?^)/?'&>C0\XQ_P!-._\
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M_5#$;ZSAN#$28S(@)3/!QZ9IHT73!<6]Q]@M_.MU"PR>6-R = #[9/YU>HH
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M'L'\ .Q?S" _C7GP_AS?I^9?4UZRM9_U^D_]?R_^@/6K65K/^OTG_K^7_P!
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M4@;E/<+0!LS^._"5M/)!/XETF.6-BKHUX@*D=01FM"?7M(MM*359]3LX]/<
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M*X>0C*.3]Y1GDMSG_P"MSC.NHHHH **** ,KQ-_R*FL?]>,W_H!K5K*\3?\
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MN;Y&M(H[F[(DN=QY4%FW.Q+\G)8ENM&I0Z!KVHG3;C4 =0LE,CP6NHO!/$K
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M71B!*=J&$*%YSQM$:C'^SSWJ.QT'1]%GEU&W1H<1L"\ES(T<49(8A%9BL:<
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MP@D.X_-L.5[\8JE87&@:CJ=V^GWEG=WL+D7*P7(D:-B%0AU!.WB(#!'\)]Z
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M[^RZ6@A9[IBRJ^\,I0A@X*_=VG')[D>M,\,1>5/J8FD62]$JK.[%RYP/ESN
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MI;7$,L=M+%!:F4F%6:)H\A3T)!&?H*EA\52WD%QI#1D:@H^R?:8\>6T^0D@
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M.5\P@9 ]A@ >P%:%%%<LY.<G)]2@HHHJ0"BBB@ HHHH **** "BBB@ HHHH
M*RM9_P!?I/\ U_+_ .@/6K65K/\ K])_Z_E_] >@#5HHHH **** ,KQ-_P B
MIK'_ %XS?^@&M6LKQ-_R*FL?]>,W_H!K5H RM)_Y"6N_]?R_^D\-:M96D_\
M(2UW_K^7_P!)X:U: "BBB@ K.;6(1J[::D%Q+*BHTKI'E(PV<;CGV-:-<OJN
M@SWNL&:"SM87>:&3^T4;$RHA&Y#WY *\'&&YH T]-\0V&JW/D6QE#-&98FDC
M*K-&#M+H>XSC\QZBJOC3_D6G_P"ONT_]*(ZJ>']"U"RO-.-ZD*1:78M91-'(
M6,VYD^;&/E&(QP>Y/IRSX@6J'P[)>%[PM%-;8B@E8!OWZ?P@@%N>/PII-NR
MZVBN6>:/R9)39>(]J F4+,V4S@]-^6XP?ESCD=<BH_M#R!1%I/B1I23N1KC8
M$YS]YI IZ=CWQ6RP]3M^*_S%='6T5R8O+2"\2'4_[4TM6CWK+>7^V-F# E P
M<C/(_#([5L1:;:R8,5_>2 8/RWKGOD=_?\JB=*</B7]>NWXA>YJ45F'2K:(*
M7O;U1E0-UX_)YP.O.<_C2KI$!4%;R_8<<_;)#T&/7_)K.PS2HK*GTVUMK>2>
M>^OHXHT+.[7DF%4+@GKZ<_7FJ5O+H5]*T-MKLDLF,[8]18G! ''S?_J-6J<Y
M)M)M(+G145@7C:-9QB2YUF>-7SM_T]\GIG #=L=NG-5H]2\.7%Z+6+7Y7G=M
MJJM])@LWS  YQG@X'U%4J%5JZB[>C_R%='445ER:;:0Q^;+?WB(#]YKUP/O9
MZY]>/IQ4,$&ESP-<0:O/+#&<-(FH,R@CG!.['?\ +%0HR:ND,VJ*Y5KFRD(3
M2I=2U*0.B;H;J4Q>^9>5X!R1GTI5@U)BFS2]251A6\[5L-G&,@!FR.>22#QG
M!-:_5ZG56]6E^>HKHZFFLZ(5#,JECA03C)ZX%<O:^&9[RYN)]5N+^%#M5+>'
M4Y64A1C<6&TYSGC\\]BX\#PW+K/+K.K27<3E[::2XSY&1@[0,#IW.3[\G->R
MIIVE/\/U_/\ "X79U5(2%!)( '4FN<7PBWEEG\0ZV;EL;IDNL9&,8"X*@=^!
MGWJH_@>6_$MMK&NZA?:>RD+;^:T9;)SEV5OFQQC 4>H-"ITNL_P?X?T@N^QU
MI= ZH64.P)"YY('7^=.KB[GP9<6T-G>VMY=:AJ]K("9+J\DC#H>'5=I(0'.>
M >@!XJT=*\0.ZA)((%!&2]_<2G&2>GR\CCCH?;%.5".\)I^NGX;V%<ZJBN.M
M]$UJ_.V;4-0TTVS&/S$N/,6ZP>'"L25&,\'N>X S)-X'>\@EBOO$.JW*,B^6
MC2[5CD48#\<D@X."<9%+V,$[3FOE=_\  _'\1W.MHKD/^$0U4QR3OXHU WG1
M!'(R0A0N I4DGW+9SSQBGV^@WVJNS:E=:A9V\;,GV>"^D'G$$C>6SN"D $ $
M'J2>:/8PWYU;KO\ @NO]7L%_(Z&[U73[%PEW>V\+D9"22 ,1].M5X?$6CSM*
MJ:A #$I=P[;,*!DMSC*X(^8<>]06WA73+)2MH+B '.?*N'4\X'4'V_GZTZZ\
M-6%\%6Y>\E".)%#74G# @@CGL14KV-[._P"'Y?\ !#4JQ>(KGRHM4GM4BT2=
M0PGD<*\*XX=QD@JQ(QCH!D]>)M2\7:)I<<C3WR,ZQK(L47SO*&!*A /O$@9X
M]O6K+Z%;2QM')/>/&P(9&NG*D$YP1G&.V/3CI5>R\*:7IT<<=FL\"1C"".=Q
M@9SCK_D "KYZ#=Y1?HGT\V[Z_GON*S&R>++!+8W2P7TEKT$\=J[*3CH !GVS
MC&:L'Q+HXE\M;Y)7(RHA5I-Q]%*@[F_V1SCG%2#1H1C_ $J_.,=;N0],^_O3
M/[!M<1@S7A$9#+FZ<X(!&>O7DU'-1_E?W_\  'J6FU&S33AJ,ES''9F,2>=(
MVU0IY!)/3J*JW'B70[2S6\GU>R2W; 60S+@YZ8YYKC].\-7W_"57FBS7EY)H
M%IMNXLW#9+/G;$>>BD,P(_V<FNBD\$:%):R6S6TGDR *ZB9AN QC)!S_  @_
M7FMZE*A2DE)MWUTML]M^HDVQX\762B22:SU*&W50Z7#VC^7*IZ%2!QGI@X/(
M]:JVM[XIU<2RPVMOI423E%CO(V:1E7.3P<%6X&1C R1GBM@Z-"<_Z5?C.>EW
M(.N/?VH.CPDG_2K_ )STNY.YSZ^U9JM3BGRP5_-W_#3^M@L^YE2W6H>([=;#
M^R;G3X9 IN9+Q5P8^I5-K<D\CG&!U'(J2?PL\LDD*ZS?PZ:P)6TB<#8Q]'Z[
M,9&PY'Z5H_V/#G/VJ_\ _ N3USZ_Y'% T>$$?Z5?\8_Y>Y/7/K_D4?6I1TIK
ME7W_ #UOK^0<O<O0PQV\*0PHL<:#:JJ, "GUG#1H1C_2K_C'6[D[9]_>@:-"
M /\ 2K_C'6[D[#'K[URMWU91HT5G?V-#C'VN_P#_  ,D],>O^3S0=&A((^UW
M_.?^7R3TQZ_Y- &C16<=&A.?]*O^<]+N3OCW]J#H\))_TJ_YSTNY.YSZ^U &
MC43VT,ES%</&#+$&5&[J&QG\\"J?]CPYS]JO_P#P+D]<^O\ D<4#1X00?M5_
MQC_E[D]<^O\ D<4TVM@-&LB+PWIT/B:7Q J/]ODA\DDM\H7C.%]>.M3#1H1C
M_2K_ (QUNY.V??WH&C0C'^E7_&.MW)V!'K[U4*DX7Y7:ZL_05C1HK._L:'&/
MM=__ .!DGICU_P GF@Z-"0?]+O\ G/\ R^2>F/7_ ">:@9HT5G'1H3G_ $J_
MYSTNY.^/?VH.CPG/^E7_ #GI=R=R#Z^U &C16=_8\.<_:K__ ,"Y/7/K_D<4
M#1X01_I5_P 8_P"7N3USZ_Y'% &C16<-&A&/]*O^,=;N3MGW]Z!HT(Q_I5_Q
MCK=R=@1Z^] &C16=_8T.,?:[_P#\#)/3'K_D\T'1H2#_ *7?\_\ 3Y)Z8]?\
MGF@#1HK..C0G/^E7_.>EW)WQ[^U!T>$Y_P!*O^<]+N3N0?7VH T:*SO['ASG
M[5?_ /@7)ZY]?\CB@:/""/\ 2K_C_I[D]<^O^1Q0!HT5G#1H1C_2K_C'6[D[
M9]_>@:-",?Z5?\8ZW<G8$>OO0!HUE:S_ *_2?^OY?_0'J3^QH<8^UW__ (&2
M>F/7_)YJAJ&GQVMYI4BSW3DWJC$L[./]6W8GV_GZT =!1110 4444 97B;_D
M5-8_Z\9O_0#6K65XF_Y%36/^O&;_ - -:M &5I/_ "$M=_Z_E_\ 2>&M6LK2
M?^0EKO\ U_+_ .D\-:M !1110 4444 %8'C3_D6G_P"ONT_]*(ZWZP/&G_(M
M/_U]VG_I1'0!OT444 (Z+(I5U#*>H(R*Q+CPGI<K0_9UEL%CW!EL', E#=0Q
M3!(SS6Y16D*LZ?P.PFDS$'A;3Y ?M[3Z@Y5DWW4F[@GL!@ @8&0 <=^M(OAJ
M"R=Y=&F?39'?>R1_-"Q[YC)QT_NX]:W**T^LU?YM.W3[MOP"R,6#097D#ZGJ
MEQ?A2&6(@1Q@YS]U?O#.,!B< =ZTKC3[.[0I<VD$RDDXDC##)Z]:L45$JTY.
M]_NT_*P610L]$TK3YS/9Z;:6\I!7?%"JG!QD9 ]A^56KFUM[R!H+F".:)NJ2
M*&!_ U+14N<V^9MW]1V,E/#&B1SI,NFP;D^X",JO&.%/ _*I/^$>T8%#_9=G
M\GW1Y*X')/3&.I/YUI45;KU7O)_>_P#,5D,AABMXA%#&D<8Z*B@ ?@*?116+
M=]6,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@! JABP !/4XZTM
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !65K/^OTG_K^7_P! >M6LK6?]?I/_ %_+_P"@
M/0!JT444 %%%% &5XF_Y%36/^O&;_P! -:M97B;_ )%36/\ KQF_] -:M &5
MI/\ R$M=_P"OY?\ TGAK5K*TG_D):[_U_+_Z3PUJT %%%% !2$A5))P!R:6D
M90RE2,@C!% &%H_B4:I=01/9M EW;M=6CF3=YD88 [ACY3\RG'/!Z\4GC3_D
M6G_Z^[3_ -*(Z;HOAJ32[JVDFO%GCLK5K2T41;2L992=QR=S811Q@<=.:MZY
MX<TW7X%2]L[:5P\9\R2%7;:L@<KD\@'!'XT :U%<_P#\(/X7_P"@%8_]^A1_
MP@_A?_H!6/\ WZ% '045S%WX \-W"1+%I-G"4E20E81\P5@2OT/2I_\ A!_"
M_P#T K'_ +]"@#H**Y__ (0?PO\ ] *Q_P"_0J"Z\ >&YVMS'I-G$(I1(P$(
M^< $;3[<_I0!T]%<_P#\(/X7_P"@%8_]^A1_P@_A?_H!6/\ WZ% '045S$O@
M#PW)>6\RZ39I'$'#1B$8?(&,_3'ZU/\ \(/X7_Z 5C_WZ% '045S_P#P@_A?
M_H!6/_?H5 _@#PVU_#.-(LUCCC=&B\D8<L5(/X;3_P!]4 =/17/_ /"#^%_^
M@%8_]^A1_P (/X7_ .@%8_\ ?H4 =!17,-X \-G4([@:19B)8GC,/DC#$E2&
M^HVD?\"J?_A!_"__ $ K'_OT* .@HKG_ /A!_"__ $ K'_OT*@_X0#PW_:'V
MC^R;/RO*\OR?)&,YSN^O:@#IZ*Y__A!_"_\ T K'_OT*/^$'\+_] *Q_[]"@
M#H**YB+P!X;CO+B9M)LWCE";(S",)@'./K4__"#^%_\ H!6/_?H4 =!17/\
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M21(8FEE=4C0%F9C@ >M<J=9L-?U"%=-LKB>\6*6-I)4:'R(74'>0V"RL0NW
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M0$'D,N6R<<9[UT6CZ2]KOOM0%M-JT^3-<10JN!VC4XW%5X R23C- &M1110
M4444 %%%% &5XF_Y%36/^O&;_P! -:M97B;_ )%36/\ KQF_] -:M &5I/\
MR$M=_P"OY?\ TGAK5K*TG_D):[_U_+_Z3PUJT %%%% #)6=87:--[A253.-Q
M[#/:O.?$7B^[NK5/LS6UG%_J;BTOU7#2@,TD,N>5&Q?E*_>+C!(KTFL*U\/.
MOB.[U>]N(;AI(Q%%&MN$VH&W+O.3O8= >,#/'- %?POHHATRPENX'4VZ[K&*
MX ::R1EP8BX/S =![8SR*Z6BB@#B=?GU_3-5BC6:*[L+R<K#',JA6+*<V\G'
M (!*/V/#9!S6EX7T!M/@6YO(1'<J72VB+AVM8&((AWC[P&,C.<9P.!6M+H^G
M3ZK#JDMG$]]"NV.8K\RCGI^9_,U>H KW\\UK833V]JUU+&NY8$8*S^P)XS7F
MWB3Q--K!6&%;:ZTRZ4J--F 1[E%VAUR?F2<2,%5>,;"3V->HGI6%HOAYM/O;
MZ^O;B&ZN[N59"T=N(E7:NT$+D_,1U;//'I0!-HVD&TCAN+QOM%^D1A%RZ!93
M%G*HY!PQ'<]"<GO6O110!P.JMKMOJR:1=K%J]G=+*(H9@J+=1_>9&./DE0<@
M_=9<]&&:Z'PQH<FE6$<E\XFU)HA'+,3EB@)*(S?Q[0<;CR:T$T?3H]6DU5;.
M(7\B;&GV_,1Q_@/R%7: *6K7\FF:>]W'9S78C(,D</+[,_,P'\1 YP.3CBO.
MM9UJYU[58+0/!>V%PZ206T#HLRJ7(BG@?KYB['=LX  P>:]/F5WAD6)Q'(5(
M5RN=IQP<=ZR/#^@C1H9FGEBN+N>=YWDCA$:J6QD(N3M!QD\G))/>@"WING?9
M!]HN#%+J,D:)<7,<?E^=MSM)&>N#_D5=D0O$Z!V0L" RXRON,TZB@#SB]3Q#
M=7MQH-_%%J;^0KQ_.(,@'"7,;@?(ZM@.O8X*\'%=KHNE#2[/$C++>2A6N[A4
M">?*% +D#@$X[5)::/IUA>7-Y:V<45Q=',TBKRY__62:O4 9FM:P-$MX[N:V
MEDL]^+B:/G[.N/OD=2H.,XZ#GH*\_>^U77_$=O:2RP27$<@>%[8IYNG2%-_F
M+SB2'8R*V[[Q;CTKTN^BN)[*6.TGC@G88222+S%!]UR,C\15/0-$BT+2H+-6
M622-2&E"!<Y8M@#LH)("YX&!0!9L;"&R65HXHDFG;S;AHEVK))@ MCMG%/OX
M)[JPFAMKI[6=T(CG10QC;L<'@_2K%% 'FTJ>(]<NKG3IXHOMUK-&ZW*2!&L'
M/26(X^>)U#?*>0=RMD<UW^GZ?;Z;:^1;1)&I8NP0;068Y8@=LG)P/6F:;H^G
M:/')'IUG%;+*^]Q&,;F]35V@#%U[7FT,QE[5FAF5E2X+@1I-_ CG^$,>-W0'
M@XR*XK2I=6USQ4&-S$][9EPE]$BAH K!9()HP>8W8-LYW#:&]Z[[7+"YU/2I
M;.VN((3*-KF>W\Y&0C!!7(]?6I=,TZ'2M/@M(<MY4:1F5OOR;5 W,>YXH DL
M[&UTZW^SV<"00[F<1H, %B2<#MR34.K07UQI[KIMVMK=J0\;NFY&(.=KCKM/
M0XY':KU,FACN()(9D5XI%*NC#(8'@@T >=V4&M^([R%I85BFL[QHY;QV7S+=
M>LMLZXQ*C C:W0@@G##GT"SL[?3[.*TM(A%;Q+MCC7HH]!3-.TVRTFS6TL+:
M.W@4DA$'&3U/N?>K5 '/:[K]QIUP;"*V\NXN4 LKF4CRGDS\R'T8+\P!^]@@
M<URWA0W?B#6)=0:2&93&JS7:HA2\MVW;89XP<"91@Y' #8/I78>)=$GU_3Q8
M)>1V]N[?O]T'F,RY!!0Y&Q@1D-SCTK7CBCA4K%&J DDA1C)/4_6@!EK:PV5K
M%:VT8C@B4)&@Z*HZ"J.NPZH]FDVD3JEU"V_R),!+A<8*$XRIYX8="!G(R*U*
M@O;*VU"SEM+N%9K>4;71NA% ' Z1I^H>);BSO+J%#;!)(+NZ<*'O(@2I@FBQ
MC>K9RPXR,K]XBO0HHD@A2*,81%"J,YP!P*9:6EO86D5K:0I#!$NU(T& HJ:@
M#E?$'B:>QDNK!8FL[A5\Z.X<!Q) J[I'C!X9UP?D//(/(K&\(6-QK9OKF^CM
MG@N?W6H>6%>WU [!B0 'Y9%X5B/E...@QU.N:'-K5S8YO(XK2WF2=X_(W2%T
M;(*OGY/0\'()'&:V(XHX8UCB141> JC 'X4 "(L:*BC"J  /:L'Q2NLQ69O-
M)N'Q%&XFMD5=SJ1]^,L,>8N,@'AN0>Q'054U+2['6+0VFH6T=Q 6#;''&10!
MR&AZ/<ZW>KJE_;6R65S;I)+Y+9COWX:*<(1F)E ]<\XY"@UW5-CC2*-8XT5$
M0!551@ #H!3J .'\1>+;R"*ZM(!_9MW;.3*TNQB8R=L4B;OE*,Q4,W\'.0.#
M2>$=(-_833WEM ME-.93;(-T+3H__'Q;MG*HY&[:>_(X/.[?Z!)J7B&RO[FZ
MB:TM-S1V_P!G&\LRE6!?/*$')7'4#GBMM5"J%4 *!@ #@4 +7*>+YM:TN*34
MK*^*6*HOGKY:LUMM.?- _B3LZ]<<J01@]75'4='T[5C =0LXKGR'\R/S%SM:
M@#G= \/7#ZC/J&I6,%I$9%FALXY!(B7 SOG1@ 5#9^[WZD9)KKSD*<#)QP*6
MB@#SS7O%]]-;HEJ\&ERQR""ZBO@K!9B<A),](B@=MZ_>X (/%:WA#15_L>RF
MN;0PP(5N+&SF 9[ D$,JN#RG/R@X(!P>P&@/#SS>)GU:]N(9XUA,,, MPI"E
ME;YVR=^"OR\#&36[0 5QOB6XU_2K^.6VNDEL;JXC2-94&(Y&^01/@9,;D\,.
M58C.5X'951N='TZ\U"VO[FSBEN[;_4RLN2GT_P \4 8GA?PZUD6N[RT6W997
M-C:;Q(;*-@ R!QU4D%MO0< =*Z2ZDEAM)I((//F1"R1!@N\@<+D\#-2T4 >8
M^)?%=QJ,*K;BV-C,K12:?>J ;@JO[Z%\_,D@)15 ');/(KL= T8VEI:RW@:6
MY@0I;/.!YT,3 ?NG8$AR,8SWP._-&F^'WMM9O]4OKB&ZGN2@4);B,(J;MI/)
MR^&QNXX XK=H *X;6Y=>L=7BLI&BU&PO))%AAF50DX92S6\AQ\K!0Q1^A *L
M.AKN:I'1].;5UU4V<1OU3RQ.5^8+_GC- &7X6T!]+M$GO5!O=K1H2V]H8"VY
M(2_\87L3_P#KUM2NIK'3YKF"SDO)(QN\B(@.XSSMSU.,D#OTJW2,"4(4[21P
M<9Q0!Y=XB\03:W<1V\?V>^TRZP8[ %4DF3<JAXW/S+.LFXXX"B,YP3FN_P!*
MTHVBI<7;I<ZEY7DR7?EA'D0$E0P!P2._;.<8S5?0M ;2Y+NYNYX;J\N9S,SQ
MP")%.T+\JY."0,DYY-;=  1D$9Q7GE^-?_M)M"U"&+6898&*1NRP_:8U8?O%
M<#Y)D++D=",,N""*]#JC;Z/IUKJ5QJ,%G$EY<#$LP7YF'^0/RH K>']';2[%
M&NI%GU*6-!=W(&#,RC )QU('&<9..:UZ** "BBB@ HHHH **** ,KQ-_R*FL
M?]>,W_H!K5K*\3?\BIK'_7C-_P"@&M6@#*TG_D):[_U_+_Z3PUJUE:3_ ,A+
M7?\ K^7_ -)X:U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#*\3?\ (J:Q_P!>,W_H!K5K*\3?
M\BIK'_7C-_Z :U: ,1(-8L]1U*2VM+&:"ZG69&DNWC88BC0@@1,.J'OWJ;[1
MK_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\
M9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW
M_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\
MT#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH
M /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &
M$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--
M_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&
MO_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_Q
MFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!
MA)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\
M0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1
MK_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\
M9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW
M_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\
MT#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH
M /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &
M$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--
M_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&
MO_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_Q
MFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!
MA)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\
M0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1
MK_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\
M9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW
M_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\
MT#--_P#!A)_\9HHH /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH
M /M&O_\ 0,TW_P &$G_QFC[1K_\ T#--_P#!A)_\9HHH /M&O_\ 0,TW_P &
M$G_QFC[1K_\ T#--_P#!A)_\9HHH J:I%X@U'2+VQ6PTQ#<P20AS?R';N4C/
*^I]ZZ"BB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %3 EP# 2(  A$! Q$!_\0
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MG_\ CE'EZ]_S]:;_ . S_P#QRM2B@#+\O7O^?K3?_ 9__CE'EZ]_S]:;_P"
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MY1Y>O?\ /UIO_@,__P <K4HH R_+U[_GZTW_ ,!G_P#CE'EZ]_S]:;_X#/\
M_'*U** ,OR]>_P"?K3?_  &?_P".4>7KW_/UIO\ X#/_ /'*U** ,OR]>_Y^
MM-_\!G_^.4>7KW_/UIO_ (#/_P#'*U** ,OR]>_Y^M-_\!G_ /CE'EZ]_P _
M6F_^ S__ !RM2B@#+\O7O^?K3?\ P&?_ ..4>7KW_/UIO_@,_P#\<K4HH R_
M+U[_ )^M-_\  9__ (Y1Y>O?\_6F_P#@,_\ \<K4HH R_+U[_GZTW_P&?_XY
M1Y>O?\_6F_\ @,__ ,<K4HH R_+U[_GZTW_P&?\ ^.4>7KW_ #]:;_X#/_\
M'*U** ,OR]>_Y^M-_P# 9_\ XY1Y>O?\_6F_^ S_ /QRM2B@#+\O7O\ GZTW
M_P !G_\ CE'EZ]_S]:;_ . S_P#QRM2B@#+\O7O^?K3?_ 9__CE'EZ]_S]:;
M_P" S_\ QRM2B@#+\O7O^?K3?_ 9_P#XY1Y>O?\ /UIO_@,__P <K4HH R_+
MU[_GZTW_ ,!G_P#CE'EZ]_S]:;_X#/\ _'*U** ,EUUU(V?[5IQV@G'V9_\
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M-,?4-1G\JW4A1A2S.Q.%50.22>@%8@^(>ABPU.ZG%[:OIL:S7-M<VKQ3*C'
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M/0@U)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 'U'_P#$5J44 9L>E2QRHYU:_<*P.UF3#>Q^7I6E110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'<?\
M'M+_ +A_E5/0O^1>TS_KTB_] %7+C_CVE_W#_*J>A?\ (O:9_P!>D7_H H C
MC_Y&JY_Z\HO_ $.2M2LN/_D:KG_KRB_]#DK4H **** "L*"VFTG4=:U V^^&
MX>$Q1PXW'"A3QVYYK=HH XC4-!U379M22^M!$6CFAL'653#"K?QD [B[XY..
M <#N2[^QM8;Q(OB4V2"="L7V(3C)3RV4MN^[G<WY#UXKM:* ,OPYILFD>'[.
MQF96FC0^85.1N)+$#VR:S[?2Y&U^_3^U+Y2L,)W!DR<E^#\O08_6NDK+M?\
MD9-1_P"N$'\Y* #^QY?^@QJ7_?:?_$4?V/+_ -!C4O\ OM/_ (BM2B@#+_L>
M7_H,:E_WVG_Q%']CR_\ 08U+_OM/_B*U** ,O^QY?^@QJ7_?:?\ Q%']CR_]
M!C4O^^T_^(K4HH R_P"QY?\ H,:E_P!]I_\ $4?V/+_T&-2_[[3_ .(K4HH
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M4?V/+_T&-2_[[3_XBM2B@#+_ +'E_P"@QJ7_ 'VG_P 11_8\O_08U+_OM/\
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M_P"/:7_</\JIZ%_R+VF?]>D7_H JY<?\>TO^X?Y53T+_ )%[3/\ KTB_] %
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M31_8TG_08U+_ +^)_P#$UJ44 9?]C2?]!C4O^_B?_$T?V-)_T&-2_P"_B?\
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M:C_UP@_G)5O3[^WU.S2ZMF+1L2/F4J58$@J0>A!!!'M52U_Y&34?^N$'\Y*
M-2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***C:>))XX&D
M42R E%/5@,9_F* .%\:^*S8WMQID7SJUFT<B]@[XP3]%R?QK-&CR6TLGA:W+
M2?;1%=&0MCY0AW \=-P&/K75Z)I=KJ*W^H7ENLYN[QV59@&"JA*+@=NAK0GT
ML-XELM3BB4%()(I7SSCC:,?]]5W*K&"Y$MOSZ'(Z<IOF?](Y[Q%83Z5X LHT
MD*W-@T3!HO[WW3_Z$:P_[(U+4],:2X5HY8GDM[K"[BJQPH5SSU)0#/O7HVJ:
M>NJ:=+:.Y0/M.X#.,$'^E68X8XBYCC53(V]\#&YNF3[\"HCB'&/G<J5#FEY6
M.'TKP8\_@J6QN956>XD%S&XY"G:-N?PSGZFM'P?)J%HUSH=_#&@L$01.N?WB
MDM\WTXKJJXKQI<W&B:I8ZU;+DF-K=@.O4-S^ 8>U$:DJS<'UU7J$H1I)273\
MC>TC_D*ZY_U]K_Z)CK7KF_!]ZVJVM_JC1B(75T66,'.T*BKR?^ UTE855:;3
M-J;O&X4445F6%%%% !1110 4444 %%%% !1110 4444 1W'_ ![2_P"X?Y53
MT+_D7M,_Z](O_0!5RX_X]I?]P_RJGH7_ "+VF?\ 7I%_Z * (X_^1JN?^O*+
M_P!#DK4K+C_Y&JY_Z\HO_0Y*U* "N8\2ZYJ.E:C9QP1;+23'F3_9WFR22",+
MTP,'WZ5T]<GKUZEOJWGB^L'C:U>V:UN;LPA6+<L" <GL>XP,'K0!T.ESW-SI
M5I/>0>1=20JTL7]QB.1^=6ZHZ,CQZ)8H]V+QU@0&X!SYIP/F_&KU 'GU_P"#
M-3U":\C_ ',<DTMRYO#*2LB2 A$\O'RD?("PYPG4YJ_+H>K7.I'7'MHH[I+F
MWD2T\[.Y(TD1OFQ@$^:Q'^Z,]>.RHH RO#VGSZ=ICI<A1//<37,BHVX(9'9]
MH/?&<5GV^E.VOW\?]IWZ[883N$BY.2_!^7H,?K72UEVO_(R:C_UP@_G)0 ?V
M,_\ T%]2_P"_J_\ Q-']C/\ ]!?4O^_J_P#Q-:E% &7_ &,__07U+_OZO_Q-
M']C/_P!!?4O^_J__ !-:E% &7_8S_P#07U+_ +^K_P#$T?V,_P#T%]2_[^K_
M /$UJ44 9?\ 8S_]!?4O^_J__$T?V,__ $%]2_[^K_\ $UJ44 9?]C/_ -!?
M4O\ OZO_ ,31_8S_ /07U+_OZO\ \36I10!E_P!C/_T%]2_[^K_\31_8S_\
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M_B:U**@HR_[&?_H+ZE_W]7_XFC^QG_Z"^I?]_5_^)K4HH R_[&?_ *"^I?\
M?U?_ (FHKC3EM8?-GUK443<JY,B]20!_#ZD5LUP7C#Q)F>\T2W/F2LL1C9/^
M6<BN6;)^BKBM:5-U)61G4FH1NSJ?[&?_ *"^I?\ ?U?_ (FN7GT75-2UZYDL
M=7N5%G(EOYDC?,%9<R8(&,\BNJMM;LIC81&=?.O(/.C4=U R3[56\,SI>6U]
M>Q9\JYO9'3/7  7^:FJAS4[RM_7](F5IV1'IGAR:RTZ&W?5K[>H)?RI %+$D
MDC*YZFK?]C/_ -!?4O\ OZO_ ,36I16+;;NS5*RLC+_L9_\ H+ZE_P!_5_\
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MCVJI:_\ (R:C_P!<(/YR4 :E%%% !1110 4444 %%%% !1110 4444 %%%%
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MV*__ $%M2_[^K_\ $UJT4 97]BO_ -!;4O\ OZO_ ,31_8K_ /06U+_OZO\
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MK7MX([6WBMX5VQQJ$4>@ P*DK.<W)MEQBDDC*_L5_P#H+:E_W]7_ .)K&N?
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MR03ECWQ6W6565Y6OHC2FK1OW,K^Q7_Z"VI?]_5_^)H_L5_\ H+:E_P!_5_\
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M/:I*FF:]9WDB2+:"SF@'E1,P#ED*C"@XX4XKG+.;Q1IFD1+#Y[R6WE6Z6;0
MJ?\ 10Q).-Q(DXSG':O1** /.4O]6@6^N;*ZNY8Y[R%9;R>V,;(GD<X'E$??
M 7.PXS@^M6(?^$BU#5+22>ZD62-GCB*6VV)&:T!\PAE#'YR>#QU&*[ZFR(LL
M;1NH9&!5@>X- '!1ZQKVIW%A=0K+;17;!,K;*S0H)8T;YBIZX<\\8P>U":YK
M<5W;Q7=U<1,+N&"-3:#%RAN&1V<[?E.T+TVCG.#D8[R**."%(HD5(T4*JJ,
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M3?U'35_??7\C+_X1^R_OWO\ X&2__%4?\(_9?W[W_P #)?\ XJM2BL#8R_\
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M%%% !1110 4444 %%%% !1110 4444 1W'_'M+_N'^54]"_Y%[3/^O2+_P!
M%7+C_CVE_P!P_P JIZ%_R+VF?]>D7_H H CC_P"1JN?^O*+_ -#DK4K+C_Y&
MJY_Z\HO_ $.2M2@ HHHH **** "BN=N/&-E9W$JW5K=P6Z><$N70;93$,N%&
M=W8X) !QQVR[_A*X55XI+"[COA-'"MFVS>YD4LI!#;<85CG/&TT =!67:_\
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M44R HHHH **** "BBB@ HHHH **** "BBB@".X_X]I?]P_RJGH7_ "+VF?\
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MJS,%58UQF1!E"7SSNR!V !TO_"/V'_3U_P"!DO\ \51_PC]A_P!/7_@9+_\
M%5J=*X_Q'XBN+6\T=K"Y!L[TXADA*%;F8LH6,N00BE2QR.3M..1@@&K:>'+>
M.V5;J6YEF!.7%U* 1DX_B],"I_\ A'[#_IZ_\#)?_BJ=HNJG5K2222W-M<03
M/!/"7#A77KAAU'(.>.O0&H-?U=K'3[U+*2-]2B@$XAQN81[L%]G4@<G'?&*
M$'ARW^VNYEN3;F,!8_M4N0^3DYW>F/RJ;_A'[#_IZ_\  R7_ .*K)\,^)I-1
M^QP7$<LD=W"\UG?DIBZ12,DJOW#AE('<>AXKI;BY@M8O-N)DBCW!=SL%&2<
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M9H78-LD0X(R."/0^E "1Z'912I(OVG<C!AFZE(R/8M@UI444 %%%% !1110
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MV<@&T[SQLD!/'?N..:IZYJ&LV^H_V5J-E#J%A=M(L<<:[#=1$9,8).%F0 D
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MC_A)-%_Z"EK_ -_!0!J45E_\))HO_04M?^_@H_X231?^@I:_]_!0!J45E_\
M"2:+_P!!2U_[^"C_ (231?\ H*6O_?P4 :E%9?\ PDFB_P#04M?^_@H_X231
M?^@I:_\ ?P4 :E%9?_"2:+_T%+7_ +^"C_A)-%_Z"EK_ -_!0!J45E_\))HO
M_04M?^_@H_X231?^@I:_]_!0!J45E_\ "2:+_P!!2U_[^"C_ (231?\ H*6O
M_?P4 :E%9?\ PDFB_P#04M?^_@H_X231?^@I:_\ ?P4 :E%9?_"2:+_T%+7_
M +^"C_A)-%_Z"EK_ -_!0!J45E_\))HO_04M?^_@H_X231?^@I:_]_!0!J45
ME_\ "2:+_P!!2U_[^"C_ (231?\ H*6O_?P4 :E%9?\ PDFB_P#04M?^_@H_
MX231?^@I:_\ ?P4 :E%9?_"2:+_T%+7_ +^"C_A)-%_Z"EK_ -_!0!J45E_\
M))HO_04M?^_@H_X231?^@I:_]_!0!J45E_\ "2:+_P!!2U_[^"C_ (231?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Nov. 13, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 414.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 13, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">414.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">414.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp237315_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp237315_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp237315_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp237315_exfilingfees.htm">dp237315_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp237315_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp237315_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2025": 1,
    "http://xbrl.sec.gov/ffd/2025": 6
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp237315_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-014670-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014670-xbrl.zip
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M%$_2,FIC4&ENP;F7$%PZ293J51#A)I;O@^JK=;A'<)AT"6J'KR]!5X]\* 5
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M<#(S-S,Q-5]E>&9I;&EN9V9E97,N:'1M4$L%!@     !  $ 1P   .0*
!  $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp237315_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-11-13</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-11-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">3000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">3000000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">414.30</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">3000000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">414.30</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">414.30</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">3000000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
